fluconazole has been researched along with Recrudescence in 195 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In previous open-label noncomparative clinical trials, both fluconazole and itraconazole were effective therapy for progressive forms of coccidioidomycosis." | 9.09 | Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group. ( Catanzaro, A; Cloud, GA; Delgado, KL; Flanigan, C; Galgiani, JN; Johnson, RH; Larsen, RA; Lutz, JE; Mirels, LF; Nassar, F; Rinaldi, MG; Sharkey, PK; Singh, VR; Stevens, DA; Williams, PL, 2000) |
| "Published opinion has generally favored amphotericin B over fluconazole as initial therapy for acquired immunodeficiency syndrome-associated cryptococcosis, although data that support this recommendation are limited." | 9.08 | Initial therapy for acquired immunodeficiency syndrome-associated cryptococcosis with fluconazole. ( Nightingale, SD, 1995) |
| "To determine the efficacy and safety of fluconazole as treatment for coccidioidomycosis." | 9.08 | Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group. ( Catanzaro, A; Chapman, SW; Cloud, G; Fierer, J; Galgiani, JN; Levine, BE; Sharkey-Mathis, PK; Stevens, DA, 1995) |
| "This multicenter, randomized, double-blind study compared the efficacy and safety of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis." | 9.08 | A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis. ( Darouiche, RO; Laine, L; Mallegol, I; Moskovitz, BL; Wilcox, CM; Wu, J, 1997) |
| "To assess the efficacy and tolerance of fluconazole in the treatment of oesophageal candidiasis, 47 AIDS patients with this infection were enrolled in an open prospective study using fluconazole 100 mg given orally once daily." | 9.07 | Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis. ( Clumeck, N; De Wit, S; Rahir, F; Urbain, D; Weerts, D, 1991) |
| "A prospective, multicenter, open study of fluconazole prophylaxis was performed in AIDS patients to evaluate the efficacy and toxicity of the drug in preventing relapses of esophageal candidiasis." | 9.07 | Clinical and mycological evaluation of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS patients. An open, multicenter study. ( Agresti, MG; Bellocco, R; Caputo, RM; Carosi, GP; Chiodo, F; de Bernardis, F; Giannini, V; Milazzo, F; Minoli, L; Mondello, F, 1994) |
| "Fluconazole 50 mg daily for 14-28 days was effective in the treatment of patients with AIDS and AIDS-related complex with severe oropharyngeal and oesophageal candidiasis." | 9.06 | Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study. ( Dunbar, EM; Ellis, ME; Leen, CL; Mandal, BK, 1990) |
| "This case report describes the successful management of a patient with diabetic ketoacidosis, who developed torsades de pointes leading to nine cardiac arrests secondary to intravenous fluconazole administration on a background of hypokalaemia and hypocalcaemia." | 7.75 | Fluconazole-induced recurrent ventricular fibrillation leading to multiple cardiac arrests. ( Arora, MK; Chakravarty, C; Singh, PM; Trikha, A, 2009) |
| " Fifteen months after the discontinuation of immunosuppressive therapy, Eschericia coli peritonitis developed, which was treated with ceftazidime intraperitoneally; he received fluconazole as prophylactic antifungal therapy during this period." | 7.72 | Successful treatment of mucormycosis peritonitis with liposomal amphotericin B in a patient on long-term peritoneal dialysis. ( Dosekun, AK; Serna, JH; Wanger, A, 2003) |
| "To determine if failure of recurrent Candida albicans vulvovaginitis to respond clinically to fluconazole is related to in vitro mycologic resistance." | 7.72 | Clinical resistance of recurrent Candida albicans vulvovaginitis to fluconazole in the presence and absence of in vitro resistance. ( Carey, JC; MacNeill, C; Weisz, J, 2003) |
| "In sequential clinical trials of treatment for histoplasmosis in patients with acquired immunodeficiency syndrome, therapy with fluconazole failed in a higher proportion of patients than did therapy with itraconazole." | 7.71 | Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome. ( Brizendine, E; Connolly, P; Hafner, R; Smedema, M; Wheat, LJ, 2001) |
| "To investigate the efficacy of pars plana vitrectomy and oral fluconazole without injection of intravitreal antimycotic agents in the treatment of vitritis resulting from Candida endophthalmitis." | 7.69 | Vitrectomy and systemic fluconazole for treatment of endogenous fungal endophthalmitis. ( Christmas, NJ; Smiddy, WE, 1996) |
| "To assess the effectiveness of fluconazole for suppression of relapse of histoplasmosis in patients with acquired immunodeficiency syndrome (AIDS)." | 7.69 | Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome. ( Baker, R; Black, J; Driks, M; Israel, K; Katz, B; Lancaster, D; McKinsey, D; Norris, S; Traeger, D; Wheat, J, 1994) |
| "Since fluconazole achieves high urine concentrations, we assessed its usefulness in the treatment of urinary candidiasis." | 7.69 | [Fluconazole in treatment of urinary candidiasis. Experience with 24 patients]. ( Castrillón, MA; del Canto, E; Pino, M; Schenone, D; Thompson, L, 1995) |
| "We have reviewed the efficacy of the use of fluconazole in patients with definitely proven Candida esophagitis (CE) associated with human immunodeficiency virus (HIV) infection, using a single 400 mg oral dose of fluconazole and evaluating the patient three days afterwards." | 7.68 | [Candida esophagitis treated with a single dose of fluconazole in patients with HIV: presentation of 11 cases]. ( Carrasco, R; Martínez, A; Medina, E; Navarro, V; Nieto, A; Roig, P; Salavert, M, 1990) |
| "In patients with the acquired immunodeficiency syndrome (AIDS), the rate of relapse after primary treatment for cryptococcal meningitis remains high." | 6.67 | A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. ( Bozzette, SA; Chiu, J; Gilbert, G; Jacobsen, J; Larsen, RA; Leal, MA; McCutchan, JA; Robinson, P; Rothman, P; Tilles, J, 1991) |
| "Fluconazole is a bis-triazole antifungal agent with a long serum half-life." | 6.67 | Fluconazole for oropharyngeal candidiasis in anti-HIV positive haemophiliacs. ( Hales, M; Kernoff, PB; Lee, CA; Lim, SG; O'Doherty, M; Winter, M, 1991) |
| "After primary treatment for cryptococcal meningitis, patients with the acquired immunodeficiency syndrome (AIDS) require some form of continued suppressive therapy to prevent relapse." | 6.67 | A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. ( Cloud, GA; Follansbee, SE; Graybill, JR; Jacobson, JM; McAuliffe, VJ; Meyer, RD; Powderly, WG; Robinson, P; Saag, MS; Sugar, AM, 1992) |
| "Micafungin (MCFG) alone was ineffective; however, the combination of MCFG with fosfluconazole (F-FLCZ) successfully treated the patient without a need for any anticoagulant or surgical therapies." | 5.39 | Successful treatment of recurrent candidemia due to candidal thrombophlebitis associated with a central venous catheter using a combination of fosfluconazole and micafungin. ( Hagiya, H; Kajioka, H, 2013) |
| "Recurrence is also more common in pregnant women, and therapeutic responses are reduced." | 5.38 | Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors. ( Aydin, M; Güzel, AB; Ilkit, M; Kalkanci, A; Khalil, II; Kuştimur, S, 2012) |
| "No differences in efficacy or safety were found between fluconazole and other azoles for the treatment of candida oesophagitis." | 5.22 | Systemic antifungal therapy for oesophageal candidiasis - systematic review and meta-analysis of randomized controlled trials. ( Atamna, A; Ayada, G; Bishara, J; Margalit, I; Matsri, S; Mwassi, HA; Shargian, L; Yahav, D, 2022) |
| "In previous open-label noncomparative clinical trials, both fluconazole and itraconazole were effective therapy for progressive forms of coccidioidomycosis." | 5.09 | Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group. ( Catanzaro, A; Cloud, GA; Delgado, KL; Flanigan, C; Galgiani, JN; Johnson, RH; Larsen, RA; Lutz, JE; Mirels, LF; Nassar, F; Rinaldi, MG; Sharkey, PK; Singh, VR; Stevens, DA; Williams, PL, 2000) |
| "This multicenter, randomized, double-blind study compared the efficacy and safety of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis." | 5.08 | A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis. ( Darouiche, RO; Laine, L; Mallegol, I; Moskovitz, BL; Wilcox, CM; Wu, J, 1997) |
| "Published opinion has generally favored amphotericin B over fluconazole as initial therapy for acquired immunodeficiency syndrome-associated cryptococcosis, although data that support this recommendation are limited." | 5.08 | Initial therapy for acquired immunodeficiency syndrome-associated cryptococcosis with fluconazole. ( Nightingale, SD, 1995) |
| "To determine the efficacy and safety of fluconazole as treatment for coccidioidomycosis." | 5.08 | Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group. ( Catanzaro, A; Chapman, SW; Cloud, G; Fierer, J; Galgiani, JN; Levine, BE; Sharkey-Mathis, PK; Stevens, DA, 1995) |
| "A prospective, multicenter, open study of fluconazole prophylaxis was performed in AIDS patients to evaluate the efficacy and toxicity of the drug in preventing relapses of esophageal candidiasis." | 5.07 | Clinical and mycological evaluation of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS patients. An open, multicenter study. ( Agresti, MG; Bellocco, R; Caputo, RM; Carosi, GP; Chiodo, F; de Bernardis, F; Giannini, V; Milazzo, F; Minoli, L; Mondello, F, 1994) |
| "To assess the efficacy and tolerance of fluconazole in the treatment of oesophageal candidiasis, 47 AIDS patients with this infection were enrolled in an open prospective study using fluconazole 100 mg given orally once daily." | 5.07 | Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis. ( Clumeck, N; De Wit, S; Rahir, F; Urbain, D; Weerts, D, 1991) |
| "After the first episode of esophageal candidiasis, 122 consecutive AIDS patients were randomly assigned to two different regimens of continuous long-term antifungal prophylaxis (ketoconazole 200 mg or fluconazole 50 mg/day p." | 5.07 | Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study. ( Antinori, S; Ardizzone, S; Bianchi Porro, G; Cernuschi, M; Esposito, R; Lazzarin, A; Moroni, M; Parente, F, 1994) |
| "In a randomised, double-blind study the efficacy and toxicity of oral fluconazole 50 mg daily and ketoconazole 200 mg daily were compared for the treatment of oropharyngeal candidiasis in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC)." | 5.06 | Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. ( Clumeck, N; De Wit, S; Goossens, H; Weerts, D, 1989) |
| "Fluconazole 50 mg daily for 14-28 days was effective in the treatment of patients with AIDS and AIDS-related complex with severe oropharyngeal and oesophageal candidiasis." | 5.06 | Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study. ( Dunbar, EM; Ellis, ME; Leen, CL; Mandal, BK, 1990) |
| "This case report describes the successful management of a patient with diabetic ketoacidosis, who developed torsades de pointes leading to nine cardiac arrests secondary to intravenous fluconazole administration on a background of hypokalaemia and hypocalcaemia." | 3.75 | Fluconazole-induced recurrent ventricular fibrillation leading to multiple cardiac arrests. ( Arora, MK; Chakravarty, C; Singh, PM; Trikha, A, 2009) |
| "To evaluate the efficacy of fluconazole as an alternative treatment for controlling hypercortisolism in Cushing's syndrome and to determine its effect on glucocorticoid production in vitro." | 3.73 | Long term control of hypercortisolism with fluconazole: case report and in vitro studies. ( Luger, A; Maier, C; Nowotny, P; Riedl, M; Schima, W; Zettinig, G, 2006) |
| "To determine if failure of recurrent Candida albicans vulvovaginitis to respond clinically to fluconazole is related to in vitro mycologic resistance." | 3.72 | Clinical resistance of recurrent Candida albicans vulvovaginitis to fluconazole in the presence and absence of in vitro resistance. ( Carey, JC; MacNeill, C; Weisz, J, 2003) |
| " Fifteen months after the discontinuation of immunosuppressive therapy, Eschericia coli peritonitis developed, which was treated with ceftazidime intraperitoneally; he received fluconazole as prophylactic antifungal therapy during this period." | 3.72 | Successful treatment of mucormycosis peritonitis with liposomal amphotericin B in a patient on long-term peritoneal dialysis. ( Dosekun, AK; Serna, JH; Wanger, A, 2003) |
| "In sequential clinical trials of treatment for histoplasmosis in patients with acquired immunodeficiency syndrome, therapy with fluconazole failed in a higher proportion of patients than did therapy with itraconazole." | 3.71 | Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome. ( Brizendine, E; Connolly, P; Hafner, R; Smedema, M; Wheat, LJ, 2001) |
| "To assess the effectiveness of fluconazole for suppression of relapse of histoplasmosis in patients with acquired immunodeficiency syndrome (AIDS)." | 3.69 | Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome. ( Baker, R; Black, J; Driks, M; Israel, K; Katz, B; Lancaster, D; McKinsey, D; Norris, S; Traeger, D; Wheat, J, 1994) |
| "To investigate the efficacy of pars plana vitrectomy and oral fluconazole without injection of intravitreal antimycotic agents in the treatment of vitritis resulting from Candida endophthalmitis." | 3.69 | Vitrectomy and systemic fluconazole for treatment of endogenous fungal endophthalmitis. ( Christmas, NJ; Smiddy, WE, 1996) |
| "Relapse after apparently successful treatment of coccidioidomycosis has been a problem with both amphotericin B and the azoles." | 3.69 | Prediction of relapse after treatment of coccidioidomycosis. ( Bone, WD; Gray, GC; Martin, CR; Oldfield, EC; Olson, P; Schillaci, RF, 1997) |
| "Since fluconazole achieves high urine concentrations, we assessed its usefulness in the treatment of urinary candidiasis." | 3.69 | [Fluconazole in treatment of urinary candidiasis. Experience with 24 patients]. ( Castrillón, MA; del Canto, E; Pino, M; Schenone, D; Thompson, L, 1995) |
| " One patient had developed a chronic systemic candidiasis during consolidation chemotherapy and received prophylactic oral or iv fluconazole (200 mg daily) throughout BMT." | 3.69 | Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases. ( Altés, A; Brunet, S; Domingo-Albós, A; Martínez, C; Martino, R; Nomdedéu, J; Sureda, A, 1994) |
| "We have reviewed the efficacy of the use of fluconazole in patients with definitely proven Candida esophagitis (CE) associated with human immunodeficiency virus (HIV) infection, using a single 400 mg oral dose of fluconazole and evaluating the patient three days afterwards." | 3.68 | [Candida esophagitis treated with a single dose of fluconazole in patients with HIV: presentation of 11 cases]. ( Carrasco, R; Martínez, A; Medina, E; Navarro, V; Nieto, A; Roig, P; Salavert, M, 1990) |
| "Fluconazole is a well-established antifungal drug commonly utilized for acute and long-term RVVC treatment." | 3.01 | Interplay of the microbiome and antifungal therapy in recurrent vulvovaginal candidiasis (RVVC): A narrative review. ( Bradfield Strydom, M; Khan, S; Tiralongo, E; Walpola, RL; Ware, RS, 2023) |
| " VT-1161 was well-tolerated with a favorable safety profile, and the incidence of adverse events was lower in all VT-1161 arms compared with placebo." | 2.87 | A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis. ( Brand, SR; Degenhardt, TP; Nyirjesy, P; Person, K; Schotzinger, RJ; Sobel, JD; Tavakkol, A, 2018) |
| "All consecutive patients with pityriasis versicolor were included and randomly divided into two groups." | 2.75 | Single-dose oral fluconazole versus topical clotrimazole in patients with pityriasis versicolor: A double-blind randomized controlled trial. ( Akbari, N; Alborzi, N; Dehghan, M; Keshtkar, AA; Sadani, S, 2010) |
| "Fluconazole therapy was well tolerated and free of serious adverse effects." | 2.70 | Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. ( Heine, MW; Hooton, T; Kapernick, PS; Nyirjesy, P; Panzer, H; Reed, BD; Sobel, JD; Soper, D; Willems, J; Wittes, H; Zervos, M, 2001) |
| "In patients with frequent recurrences, continuous suppressive therapy significantly reduced relapses and colonization." | 2.69 | A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance. ( Dib, OP; Fothergill, AW; Hilsenbeck, SG; Kirkpatrick, WR; McAtee, RK; Patterson, TF; Redding, SW; Revankar, SG; Rinaldi, MG, 1998) |
| "Invasive fungal infections have increasingly become a matter of concern with regard to patients receiving intensive myelosuppressive therapy for hematologic malignancies." | 2.69 | Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group. ( Behre, G; Büchner, T; Eimermacher, H; Grote-Metke, A; Hiddemann, W; Kerkhoff, A; Kern, W; Kubica, U; Rudolf, T; Wörmann, B, 1998) |
| "Fluconazole compliance was monitored electronically by using the Medication Event Monitoring Systems with 19 women receiving fluconazole at 50 mg thrice weekly for prophylaxis of recurrent mucocutaneous candidiasis." | 2.68 | Electronic compliance assessment of antifungal prophylaxis for human immunodeficiency virus-infected women. ( Bettencourt, FA; Dudley, MN; Fiore, TC; Flanigan, TP; Geletko, SM; Mayer, KH; Segarra, M, 1996) |
| "Fluconazole was well tolerated and prevented clinical relapse of oropharyngeal candidiasis in 71% of patients who completed three months of treatment (95% confidence interval [CI], 55-86) and 58% (95% CI, 41-75) who completed six months of treatment." | 2.67 | Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV-infected patients. A double-blind placebo-controlled study. ( Harkness, JL; Hoy, JF; Jones, PD; Marriott, DJ; Speed, BR, 1993) |
| "After primary treatment for cryptococcal meningitis, patients with the acquired immunodeficiency syndrome (AIDS) require some form of continued suppressive therapy to prevent relapse." | 2.67 | A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. ( Cloud, GA; Follansbee, SE; Graybill, JR; Jacobson, JM; McAuliffe, VJ; Meyer, RD; Powderly, WG; Robinson, P; Saag, MS; Sugar, AM, 1992) |
| " In group 2, on 57 of 3316 days (2%), fluconazole in a higher dosage was administered for treatment." | 2.67 | Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients. ( Gentschew, G; Helm, EB; Just-Nübling, G; Meissner, K; Odewald, J; Staszewski, S; Stille, W, 1991) |
| "Fluconazole is a bis-triazole antifungal agent with a long serum half-life." | 2.67 | Fluconazole for oropharyngeal candidiasis in anti-HIV positive haemophiliacs. ( Hales, M; Kernoff, PB; Lee, CA; Lim, SG; O'Doherty, M; Winter, M, 1991) |
| "In patients with the acquired immunodeficiency syndrome (AIDS), the rate of relapse after primary treatment for cryptococcal meningitis remains high." | 2.67 | A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. ( Bozzette, SA; Chiu, J; Gilbert, G; Jacobsen, J; Larsen, RA; Leal, MA; McCutchan, JA; Robinson, P; Rothman, P; Tilles, J, 1991) |
| "Mean fluconazole resistance was 10." | 2.58 | A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species. ( Bongomin, F; Gago, S; Moore, CB; Oladele, RO; Richardson, MD, 2018) |
| "Eight patients had symptomatic recurrence of lesions 3-12 weeks after treatment and underwent reoperation." | 2.52 | Intracranial Fungal Granulomas: A Single Institutional Clinicopathologic Study of 66 Patients and Review of the Literature. ( Ahmed, FU; Garg, A; Gupta, A; Mahapatra, AK; Naik, V; Sarkar, C; Sharma, B, 2015) |
| "Vulvovaginal candidiasis is considered recurrent when at least four specific episodes occur in one year or at least three episodes unrelated to antibiotic therapy occur within one year." | 2.41 | Treatment of recurrent vulvovaginal candidiasis. ( Ringdahl, EN, 2000) |
| " Intermittent pulse dosing with itraconazole is as safe and effective as short-term continuous therapy but more economical and convenient." | 2.41 | Treating onychomycosis. ( Bassler, M; Rodgers, P, 2001) |
| "There is a wide range of drugs to treat or suppress Candida infections." | 2.39 | Resistant candidiasis. ( Powderly, WG, 1994) |
| "Fluconazole is an effective treatment for cryptococcal meningitis." | 2.39 | The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection. ( Cartledge, J; Fisher, M; Gazzard, BG; Nelson, MR; Rogers, T, 1994) |
| "He had multiple prior episodes of cryptococcal meningitis with complications necessitating ventriculoperitoneal shunt placement and was on suppressive fluconazole when he developed worsening brain manifestations." | 1.56 | Case Report: A Case of Severe Cryptococcal Immune Reconstitution Inflammatory Syndrome Presenting with Brain and Intradural Abscesses in an HIV Patient. ( Jeng, A; Kalinoski, T; Malenfant, J; Yim, C, 2020) |
| "We experienced a rare case of acute pancreatitis caused by Candida infection." | 1.51 | A rare case of acute pancreatitis caused by Candida Albicans. ( Aono, M; Hiasa, Y; Hida, AI; Joko, K; Kumagi, T; Mashiba, T; Ochi, H; Oshiro, Y; Sunago, K; Takechi, S; Tange, K; Yokota, T, 2019) |
| "We aimed to determine the rate of recurrence at a minimum of 6 months after completion of maintenance therapy." | 1.48 | Long-Term Outcomes of Women With Recurrent Vulvovaginal Candidiasis After a Course of Maintenance Antifungal Therapy. ( Crouss, T; Nyirjesy, P; Smith, K; Sobel, JD, 2018) |
| "Cryptococcosis is an important opportunistic infection of organ transplant recipients." | 1.48 | Cryptococcoma of a transplanted kidney in a patient presenting with recurrent urinary tract infection: a case report. ( Greeff, L; Karusseit, VOL; Lengano, T; Muranda, AZ; Sathekge, MM, 2018) |
| "Recurrent vulvovaginal candidiasis is defined as having three to four episodes per year and causes substantial suffering." | 1.46 | Elevated nitric oxide in recurrent vulvovaginal candidiasis - association with clinical findings. ( Alvendal, C; Bohm-Starke, N; Brauner, A; Ehrström, S; Lundberg, JO, 2017) |
| "It often causes recurrence of symptoms probably due to its antifungal resistance." | 1.46 | A Case Report of Penile Infection Caused by Fluconazole- and Terbinafine-Resistant Candida albicans. ( Han, X; Hu, Y; Huang, S; Liu, K; Lu, Y; Mao, Z; Wu, Z; Zhou, X, 2017) |
| "Our case challenges the concept that immune reconstitution inflammatory syndrome and microbiological relapse are dichotomous entities." | 1.42 | Cryptococcal meningoencephalitis relapse after an eight-year delay: an interplay of infection and immune reconstitution. ( Arastéh, K; Blechschmidt, C; Boulware, DR; Branding, G; Katchanov, J; Meintjes, G; Nielsen, K; Stocker, H; Tintelnot, K, 2015) |
| "Micafungin (MCFG) alone was ineffective; however, the combination of MCFG with fosfluconazole (F-FLCZ) successfully treated the patient without a need for any anticoagulant or surgical therapies." | 1.39 | Successful treatment of recurrent candidemia due to candidal thrombophlebitis associated with a central venous catheter using a combination of fosfluconazole and micafungin. ( Hagiya, H; Kajioka, H, 2013) |
| "In many resource-limited settings, cryptococcal meningitis (CM) contributes up to 20% of all deaths with further complications due to Immune Reconstitution Inflammatory Syndrome (IRIS)." | 1.38 | Challenges in diagnosis and management of Cryptococcal immune reconstitution inflammatory syndrome (IRIS) in resource limited settings. ( Bohjanen, P; Lukande, R; Mayanja-Kizza, H; Meya, BD; Musubire, AK; R Boulware, RD; Wiesner, LD, 2012) |
| "Recurrence is also more common in pregnant women, and therapeutic responses are reduced." | 1.38 | Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors. ( Aydin, M; Güzel, AB; Ilkit, M; Kalkanci, A; Khalil, II; Kuştimur, S, 2012) |
| "Otomycosis is frequently seen in Shanghai and is a challenging problem due to recurrence and resistance to therapy." | 1.38 | Otomycosis in Shanghai: aetiology, clinical features and therapy. ( Cao, W; Chi, F; Jia, X; Liang, Q, 2012) |
| "Mostly, recurrences are caused by identical Candida strains suggesting C." | 1.37 | Recurrent vulvovaginal candidosis: focus on the vulva. ( Beikert, FC; Clad, A; Koeninger, A; Le, MT; Technau, K, 2011) |
| "Cryptococcal meningitis is the commonest cause of adult meningitis in Southern Africa." | 1.36 | Symptomatic relapse of HIV-associated cryptococcal meningitis in South Africa: the role of inadequate secondary prophylaxis. ( Harrison, TS; Jarvis, JN; Meintjes, G; Rebe, K; Williams, Z, 2010) |
| "parapsilosis infection without recurrence was confirmed." | 1.36 | Candida parapsilosis meningitis associated with shunt infection in an adult male. ( Bagheri, F; Cervellione, KL; Marino, W; Maruf, M; Santucci, T, 2010) |
| "Two HIV-infected patients had recurrent cryptococcal meningitis (CM) despite treatment with fluconazole and immune reconstitution with combination antiretroviral therapy (CART)." | 1.35 | Recurrence of cryptococcal meningitis in HIV-infected patients following immune reconstitution. ( Corbett, EL; Ferrand, RA; Mangeya, N; Miller, RF; Seddon, J, 2009) |
| "Voriconazole was highly active (MIC50 0." | 1.35 | Trends in frequency and in vitro antifungal susceptibility patterns of Candida isolates from women attending the STD outpatients clinic of a tertiary care hospital in Northern Italy during the years 2002-2007. ( Asticcioli, S; Daturi, R; Matti, C; Nucleo, E; Pagani, L; Sacco, L; Zara, F, 2009) |
| "Because of cardiac tamponade, the pericardium was surgically drained." | 1.33 | [A man with Candida pyopneumopericarditis and cardiac tamponade in conjunction with gastric tube infection]. ( Landman, JJ; van Beek, LM; Verheught, FW, 2005) |
| "To determine the prevalence of allergy in patients with recurrent vaginal candidiasis (RVC) and the efficacy of fluconazole in combination with an antihistamine drug in RVC patients who do not respond to fluconazole alone." | 1.33 | Successful treatment of refractory recurrent vaginal candidiasis with cetirizine plus fluconazole. ( Carvalho, EM; Carvalho, LP; Cruz, A; Lopes, AC; Neves, NA, 2005) |
| "Fluconazole was therefore continued orally for a total of 60 days, and the patient remained asymptomatic for 2 years." | 1.33 | Recurrent Candida tropicalis meningitis. ( Alvarez, S; Dawson, NL; Robles, HA, 2005) |
| "Fluconazole is useful in the treatment of CNS cryptococcosis, because it attains high concentration in the CNS." | 1.32 | Cryptococcosis of the central nervous system in a dog. ( O'Toole, TE; Rozanski, EA; Sato, AF, 2003) |
| "There are few reports on cryptococcal meningitis in non-HIV-infected patients in subtropical areas." | 1.31 | Cryptococcal meningitis in non-HIV-infected patients. ( Chang, SC; Chen, YC; Hsieh, WC; Luh, KT; Shih, CC, 2000) |
| "Of the 22 women who experienced recurrence, the same strain was responsible for the initial and recurrent episode in 17 women." | 1.31 | An investigation into the pathogenesis of vulvo-vaginal candidosis. ( Ashbee, HR; Barton, RC; El-Din, SS; Evans, EG; Reynolds, MT, 2001) |
| "Treatment of recurrence or persistence was again most commonly nystatin for both mother and infant, followed by oral nystatin for the infant and oral fluconazole for the mother or oral fluconazole for both." | 1.31 | Thrush in the breastfeeding dyad: results of a survey on diagnosis and treatment. ( Brent, NB, 2001) |
| "Fluconazole has been found effective by physicians and patients." | 1.30 | Single-dose systemic oral fluconazole for the treatment of vaginal candidiasis. ( Gibor, Y; Kaplan, B; Rabinerson, D, 1997) |
| "Medical treatment of fungal endocarditis on prosthetic valves can be successful in selected cases." | 1.30 | A case of recurrent Candida parapsilosis prosthetic valve endocarditis: cure by medical treatment alone. ( Kozelj, M; Lejko-Zupanc, T, 1997) |
| " glabrata was less susceptible (4-8 mg/l) or resistant (> 8 mg/l) to fluconazole and resistant to itraconazole and ketoconazole High dosed intravenous fluconazole treatment with 400 to 600 mg daily failed in 11 patients with fluconazole resistant C." | 1.30 | [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole]. ( Hofmann, H; Metzger, S, 1997) |
| "Almost all patients with acquired immunodeficiency syndrome and successfully treated esophageal candidiasis develop a recurrence, usually within 2-3 months." | 1.29 | The natural history of esophageal candidiasis after successful treatment in patients with AIDS. ( Laine, L, 1994) |
| "Cryptococcal meningitis was diagnosed in a 71-year-old male diabetic patient with underlying ischaemic heart disease, asthma and bilateral axillo-femoral vascular grafts." | 1.29 | Pyrolysis typing of isolates from a recurrence of systemic cryptococcosis. ( Hosein, IK; Magee, JT; Philpot, C; Yang, J, 1994) |
| "Fungal endocarditis is considered an absolute indication for valve replacement surgery." | 1.29 | Medical treatment of recurrent candidemia in a patient with probable Candida parapsilosis prosthetic valve endocarditis. ( Hinthorn, DR; Klotz, SA; Zahid, MA, 1994) |
| "Fluconazole was reasonably well tolerated." | 1.29 | Treatment of Candida albicans fungaemia with fluconazole. ( Georgopoulos, A; Graninger, W; Presteril, E; Schneeweiss, B; Teleky, B, 1993) |
| "Patients with cryptococcal meningitis tend to have recurrences of infection." | 1.29 | Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. ( Casadevall, A; Freundlich, LF; Spitzer, ED; Spitzer, SG, 1993) |
| "The drug proved effective and safe." | 1.29 | [Use of Diflucan in the treatment of chronic and recurrent candidosis with involvement of the esophagus]. ( Antonov, VV; Barantsevich, EP; Nizamutdinova, AS, 1996) |
| " Because amphotericin B nephrotoxicity was suspected, further intravenous administration was stopped after a cumulative dosage of 2 g." | 1.28 | [Cryptococcal meningitis in AIDS: successful long-term prophylaxis with fluconazole]. ( Glück, T; Weber, P; Wiedmann, KH, 1991) |
| "Treatment with ketoconazole and potassium iodide did not prevent several relapses." | 1.28 | Rhinofacial zygomycosis caused by Conidiobolus coronatus. A case report. ( Costa, AR; Cucé, LC; dos Reis, VM; Lacaz, Cda S; Müller, H; Pegas, JR; Pires, MC; Porto, E; Rodrigues, MC, 1991) |
| "To meet criteria for adequate treatment of meningitis all patients had two sequential cerebrospinal fluid samples which were culture negative." | 1.28 | Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group. ( Bozzette, S; Chiu, J; Larsen, RA; Leal, MA; McCutchan, JA; Richman, DD, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (1.54) | 18.7374 |
| 1990's | 79 (40.51) | 18.2507 |
| 2000's | 48 (24.62) | 29.6817 |
| 2010's | 56 (28.72) | 24.3611 |
| 2020's | 9 (4.62) | 2.80 |
| Authors | Studies |
|---|---|
| Sobel, JD | 7 |
| Nyirjesy, P | 5 |
| Mwassi, HA | 1 |
| Yahav, D | 1 |
| Ayada, G | 1 |
| Matsri, S | 1 |
| Margalit, I | 1 |
| Shargian, L | 1 |
| Bishara, J | 1 |
| Atamna, A | 1 |
| Lietz, A | 1 |
| Eckel, F | 1 |
| Kiss, H | 1 |
| Noe-Letschnig, M | 1 |
| Farr, A | 1 |
| Bradfield Strydom, M | 1 |
| Khan, S | 1 |
| Walpola, RL | 1 |
| Ware, RS | 1 |
| Tiralongo, E | 1 |
| Collins, LM | 1 |
| Moore, R | 1 |
| Donders, GG | 2 |
| Grinceviciene, S | 5 |
| Ruban, K | 4 |
| Bellen, G | 6 |
| Kalinoski, T | 1 |
| Malenfant, J | 1 |
| Yim, C | 1 |
| Jeng, A | 1 |
| Piech, TL | 1 |
| Jaffey, JA | 1 |
| Hostnik, ET | 1 |
| White, ME | 1 |
| Tey, A | 1 |
| Mohan, B | 1 |
| Cheah, R | 1 |
| Dendle, C | 1 |
| Gregory, G | 1 |
| Donders, G | 1 |
| Dev, T | 1 |
| Saginatham, H | 1 |
| Sethuraman, G | 1 |
| Başaran, S | 1 |
| Karabıçak, N | 1 |
| Şimşek Yavuz, S | 1 |
| Wiederhold, NP | 1 |
| Şafak, S | 1 |
| Sarıbuğa, A | 1 |
| Sutton, DA | 1 |
| Bingöl, Z | 1 |
| Çağatay, A | 1 |
| Özsüt, H | 1 |
| Kılıçaslan, Z | 1 |
| Eraksoy, H | 1 |
| de Carvalho Santana, R | 1 |
| Schiave, LA | 1 |
| Dos Santos Quaglio, AS | 1 |
| de Gaitani, CM | 1 |
| Martinez, R | 1 |
| Xie, HY | 1 |
| Feng, D | 1 |
| Wei, DM | 1 |
| Mei, L | 1 |
| Chen, H | 1 |
| Wang, X | 1 |
| Fang, F | 1 |
| Spec, A | 1 |
| Connolly, P | 2 |
| Montejano, R | 1 |
| Wheat, LJ | 3 |
| Bongomin, F | 1 |
| Oladele, RO | 1 |
| Gago, S | 1 |
| Moore, CB | 1 |
| Richardson, MD | 1 |
| Donders, GGG | 3 |
| Jaeger, M | 1 |
| Ten Oever, J | 1 |
| Netea, MG | 1 |
| Brand, SR | 1 |
| Degenhardt, TP | 1 |
| Person, K | 1 |
| Schotzinger, RJ | 1 |
| Tavakkol, A | 1 |
| Crane, JK | 1 |
| Muranda, AZ | 1 |
| Greeff, L | 1 |
| Sathekge, MM | 1 |
| Lengano, T | 1 |
| Karusseit, VOL | 1 |
| Crouss, T | 1 |
| Smith, K | 1 |
| Tange, K | 1 |
| Yokota, T | 1 |
| Sunago, K | 1 |
| Aono, M | 1 |
| Ochi, H | 1 |
| Takechi, S | 1 |
| Mashiba, T | 1 |
| Hida, AI | 1 |
| Oshiro, Y | 1 |
| Joko, K | 1 |
| Kumagi, T | 1 |
| Hiasa, Y | 1 |
| Quint, T | 1 |
| Wöhrl, S | 1 |
| Kinaciyan, T | 1 |
| Genovese, C | 1 |
| Cianci, A | 1 |
| Corsello, S | 1 |
| Ettore, G | 1 |
| Mattana, P | 1 |
| Tempera, G | 1 |
| Lírio, J | 1 |
| Giraldo, PC | 1 |
| Amaral, RL | 1 |
| Sarmento, ACA | 1 |
| Costa, APF | 1 |
| Gonçalves, AK | 1 |
| Agnelli, C | 1 |
| Guinea, J | 2 |
| Valerio, M | 1 |
| Escribano, P | 1 |
| Bouza, E | 2 |
| Muñoz, P | 2 |
| Helou, J | 1 |
| Obeid, G | 1 |
| Moutran, R | 1 |
| Maatouk, I | 1 |
| Hagiya, H | 1 |
| Kajioka, H | 1 |
| Kubisiak-Rzepczyk, H | 1 |
| Gil, L | 1 |
| Zawirska, A | 1 |
| Kubisiak-Michalska, A | 1 |
| Mol, A | 1 |
| Reich, A | 1 |
| Komarnicki, M | 1 |
| Adamski, Z | 1 |
| Nelson, S | 1 |
| Vytopil, M | 1 |
| Bal, AM | 1 |
| Shankland, GS | 1 |
| Scott, G | 1 |
| Imtiaz, T | 1 |
| Macaulay, R | 1 |
| McGill, M | 1 |
| D'Antuono, A | 1 |
| Bellavista, S | 1 |
| Gaspari, V | 1 |
| Filippini, A | 1 |
| Patrizi, A | 1 |
| Gunther, LS | 1 |
| Martins, HP | 1 |
| Gimenes, F | 1 |
| Abreu, AL | 1 |
| Consolaro, ME | 1 |
| Svidzinski, TI | 1 |
| Erami, M | 1 |
| Afzali, H | 1 |
| Heravi, MM | 1 |
| Rezaei-Matehkolaei, A | 1 |
| Najafzadeh, MJ | 1 |
| Moazeni, M | 1 |
| Dolatabadi, S | 1 |
| Hosseinpour, L | 1 |
| Satyanarayan, A | 1 |
| Klotz, S | 1 |
| Han, L | 1 |
| Sobonya, R | 1 |
| Zangeneh, TT | 1 |
| Fan, S | 1 |
| Liu, X | 1 |
| Wu, C | 1 |
| Xu, L | 1 |
| Li, J | 1 |
| Katchanov, J | 1 |
| Blechschmidt, C | 1 |
| Nielsen, K | 1 |
| Branding, G | 1 |
| Arastéh, K | 1 |
| Tintelnot, K | 1 |
| Meintjes, G | 3 |
| Boulware, DR | 1 |
| Stocker, H | 1 |
| Naik, V | 1 |
| Ahmed, FU | 1 |
| Gupta, A | 1 |
| Garg, A | 1 |
| Sarkar, C | 1 |
| Sharma, B | 1 |
| Mahapatra, AK | 1 |
| Kubiak, DW | 1 |
| Farmakiotis, D | 1 |
| Arons, V | 1 |
| Hollins, RM | 1 |
| Rostas, SE | 1 |
| Weiser, LM | 1 |
| Baden, LR | 1 |
| Marty, FM | 1 |
| Koo, S | 1 |
| Boatto, HF | 1 |
| Cavalcanti, SD | 1 |
| Del Negro, GM | 1 |
| Girão, MJ | 1 |
| Francisco, EC | 1 |
| Ishida, K | 1 |
| Gompertz, OF | 1 |
| Ouadi, Z | 1 |
| Akhdari, N | 1 |
| Hocar, O | 1 |
| Amal, S | 1 |
| Tassi, N | 1 |
| Hu, Y | 2 |
| Lu, Y | 1 |
| Huang, S | 1 |
| Liu, K | 1 |
| Han, X | 1 |
| Mao, Z | 1 |
| Wu, Z | 1 |
| Zhou, X | 1 |
| Rammaert, B | 1 |
| Candon, S | 1 |
| Maunoury, C | 1 |
| Bougnoux, ME | 1 |
| Jouvion, G | 1 |
| Braun, T | 1 |
| Correas, JM | 1 |
| Lortholary, O | 2 |
| Alvendal, C | 1 |
| Ehrström, S | 1 |
| Brauner, A | 1 |
| Lundberg, JO | 1 |
| Bohm-Starke, N | 1 |
| Babula, O | 1 |
| Linhares, IM | 1 |
| Witkin, SS | 1 |
| Benedix, F | 1 |
| Schilling, M | 1 |
| Schaller, M | 1 |
| Röcken, M | 1 |
| Biedermann, T | 1 |
| Seilmaier, M | 1 |
| Hecht, A | 1 |
| Guggemos, W | 1 |
| Rüdisser, K | 1 |
| How, SH | 1 |
| Kuan, YC | 1 |
| Ng, TH | 1 |
| Ramachandram, K | 1 |
| Fauzi, AR | 1 |
| Seddon, J | 1 |
| Mangeya, N | 1 |
| Miller, RF | 1 |
| Corbett, EL | 1 |
| Ferrand, RA | 1 |
| Pérez Melón, C | 1 |
| Conde Rivera, O | 1 |
| Novoa Fernández, E | 1 |
| Borrajo Prol, M | 1 |
| Chakravarty, C | 1 |
| Singh, PM | 1 |
| Trikha, A | 1 |
| Arora, MK | 1 |
| Shahid, Z | 1 |
| Asticcioli, S | 1 |
| Sacco, L | 1 |
| Daturi, R | 1 |
| Matti, C | 1 |
| Nucleo, E | 1 |
| Zara, F | 1 |
| Pagani, L | 1 |
| Chandran, SK | 1 |
| Lyons, KM | 1 |
| Divi, V | 1 |
| Geyer, M | 1 |
| Sataloff, RT | 1 |
| Moreira, T | 1 |
| Lago, P | 1 |
| Salgado, M | 1 |
| Pimentel, R | 1 |
| Binning, MJ | 1 |
| Lee, J | 1 |
| Thorell, EA | 1 |
| Riva-Cambrin, JK | 1 |
| Bagheri, F | 1 |
| Cervellione, KL | 1 |
| Maruf, M | 1 |
| Marino, W | 1 |
| Santucci, T | 1 |
| Auler, ME | 1 |
| Morreira, D | 1 |
| Rodrigues, FF | 1 |
| Abr Ao, MS | 1 |
| Margarido, PF | 1 |
| Matsumoto, FE | 1 |
| Silva, EG | 1 |
| Silva, BC | 1 |
| Schneider, RP | 1 |
| Paula, CR | 1 |
| Persad, P | 1 |
| Patel, R | 1 |
| Stephens, J | 1 |
| Francis-Rogers, S | 1 |
| Talat, P | 1 |
| Jarvis, JN | 1 |
| Williams, Z | 1 |
| Rebe, K | 1 |
| Harrison, TS | 1 |
| Dehghan, M | 1 |
| Akbari, N | 1 |
| Alborzi, N | 1 |
| Sadani, S | 1 |
| Keshtkar, AA | 1 |
| Lopatin, AS | 1 |
| Ovchinnikov, AIu | 1 |
| Beikert, FC | 1 |
| Le, MT | 1 |
| Koeninger, A | 1 |
| Technau, K | 1 |
| Clad, A | 1 |
| Davis, JD | 1 |
| Harper, AL | 1 |
| Smego, RA | 1 |
| Ahmad, H | 1 |
| Hamoud, S | 1 |
| Keidar, Z | 1 |
| Hayek, T | 1 |
| Jia, X | 1 |
| Liang, Q | 1 |
| Chi, F | 1 |
| Cao, W | 1 |
| Sundi, D | 1 |
| Tseng, K | 1 |
| Mullins, JK | 1 |
| Marr, KA | 1 |
| Hyndman, ME | 1 |
| Gallè, F | 1 |
| Sanguinetti, M | 1 |
| Colella, G | 1 |
| Di Onofrio, V | 1 |
| Torelli, R | 1 |
| Rossano, F | 1 |
| Liguori, G | 1 |
| Kalkanci, A | 1 |
| Güzel, AB | 1 |
| Khalil, II | 1 |
| Aydin, M | 1 |
| Ilkit, M | 1 |
| Kuştimur, S | 1 |
| Kresch, ZA | 1 |
| Espinosa-Heidmann, D | 1 |
| Harper, T | 1 |
| Jamie Miller, G | 1 |
| Selvakumar, P | 1 |
| Sofia, O | 1 |
| Gopal, L | 2 |
| Biswas, J | 2 |
| Gomez-Moyano, E | 1 |
| Cid Lama, A | 1 |
| Fernández Ballesteros, MD | 1 |
| Lova Navarro, M | 1 |
| Vera Casaño, A | 1 |
| Crespo Erchiga, V | 1 |
| Musubire, AK | 1 |
| Meya, BD | 1 |
| Mayanja-Kizza, H | 1 |
| Lukande, R | 1 |
| Wiesner, LD | 1 |
| Bohjanen, P | 1 |
| R Boulware, RD | 1 |
| King, MD | 1 |
| Perlino, CA | 1 |
| Cinnamon, J | 1 |
| Jernigan, JA | 1 |
| Miyabe, S | 1 |
| Koizuka, I | 1 |
| Ochi, K | 1 |
| Tanaka, K | 1 |
| Kuroda, H | 1 |
| Kenmochi, M | 1 |
| Okada, T | 1 |
| Tomisawa, H | 1 |
| Sugiyama, Y | 1 |
| Mathew, G | 1 |
| Smedema, M | 2 |
| Goldman, M | 1 |
| MacNeill, C | 1 |
| Weisz, J | 1 |
| Carey, JC | 1 |
| Sandhu, S | 1 |
| Kaur, T | 1 |
| O'Toole, TE | 1 |
| Sato, AF | 1 |
| Rozanski, EA | 1 |
| Serna, JH | 1 |
| Wanger, A | 1 |
| Dosekun, AK | 1 |
| Rodero, L | 2 |
| Mellado, E | 1 |
| Rodriguez, AC | 1 |
| Salve, A | 1 |
| Guelfand, L | 2 |
| Cahn, P | 2 |
| Cuenca-Estrella, M | 1 |
| Davel, G | 2 |
| Rodriguez-Tudela, JL | 2 |
| Goldstein, MH | 1 |
| Lim, M | 1 |
| Driebe, WT | 1 |
| Pietrobon, D | 1 |
| Negro-Marquínez, L | 1 |
| Kilstein, J | 1 |
| Galíndez, J | 1 |
| Greca, A | 1 |
| Battagliotti, C | 1 |
| Dawson, NL | 1 |
| Robles, HA | 1 |
| Alvarez, S | 1 |
| Martínez-Baltanás, A | 1 |
| Cuadrado, JM | 1 |
| Jover, F | 1 |
| Roig, P | 2 |
| Hussey, SM | 1 |
| Gander, R | 1 |
| Southern, P | 1 |
| Hoang, MP | 1 |
| Ventolini, G | 1 |
| Baggish, MS | 1 |
| Neves, NA | 1 |
| Carvalho, LP | 1 |
| Lopes, AC | 1 |
| Cruz, A | 1 |
| Carvalho, EM | 1 |
| van Beek, LM | 1 |
| Landman, JJ | 1 |
| Verheught, FW | 1 |
| Riedl, M | 1 |
| Maier, C | 1 |
| Zettinig, G | 1 |
| Nowotny, P | 1 |
| Schima, W | 1 |
| Luger, A | 1 |
| Hinterseer, M | 1 |
| Irlbeck, M | 1 |
| Ney, L | 1 |
| Beckmann, BM | 1 |
| Pfeufer, A | 1 |
| Steinbeck, G | 1 |
| Kaab, S | 1 |
| Bicanic, T | 1 |
| Harrison, T | 1 |
| Niepieklo, A | 1 |
| Dyakopu, N | 1 |
| Poizat, G | 1 |
| Zeller, V | 1 |
| Neuville, S | 1 |
| Boibieux, A | 1 |
| Alvarez, M | 1 |
| Dellamonica, P | 1 |
| Botterel, F | 1 |
| Dromer, F | 1 |
| Chêne, G | 1 |
| Bae, WK | 1 |
| Lee, KS | 1 |
| Park, JW | 1 |
| Bae, EH | 1 |
| Ma, SK | 1 |
| Kim, NH | 1 |
| Choi, KC | 1 |
| Shin, JH | 1 |
| Cho, HH | 1 |
| Cho, YB | 1 |
| Kim, SW | 1 |
| Palomo, J | 1 |
| Yañez, J | 1 |
| Giannella, M | 1 |
| Pantazidou, A | 1 |
| Tebruegge, M | 1 |
| Hanninen, M | 1 |
| Dean, N | 1 |
| Seeney, SM | 1 |
| Grody, MH | 1 |
| Jordan, CA | 1 |
| Buckley, HR | 1 |
| Viard, JP | 1 |
| Hennequin, C | 1 |
| Fortineau, N | 1 |
| Pertuiset, N | 1 |
| Rothschild, C | 1 |
| Zylberberg, H | 1 |
| Diz Dios, PD | 1 |
| Alvarez Alvarez, J | 1 |
| Fernández Feijoo, J | 1 |
| Castro Ferreiro, M | 1 |
| Arikan, A | 1 |
| Kulak, Y | 1 |
| Kadir, T | 1 |
| Flynn, PM | 1 |
| Cunningham, CK | 1 |
| Kerkering, T | 1 |
| San Jorge, AR | 1 |
| Peters, VB | 1 |
| Pitel, PA | 1 |
| Harris, J | 1 |
| Gilbert, G | 2 |
| Castagnaro, L | 1 |
| Robinson, P | 3 |
| L'Her, P | 1 |
| Savuth, C | 1 |
| Than, T | 1 |
| San, KK | 1 |
| Vuthea, KS | 1 |
| Leang, S | 1 |
| Sophouen, N | 1 |
| Arborio, M | 1 |
| Brooker, D | 1 |
| Stein, GE | 1 |
| Thomason, JL | 1 |
| Wermeling, DP | 1 |
| Bradley, B | 1 |
| Weinstein, L | 1 |
| Laguna, F | 2 |
| Martínez-Suárez, JV | 2 |
| Adrados, M | 1 |
| Powderly, WG | 2 |
| Metzger, S | 2 |
| Jäger, H | 1 |
| Hofmann, H | 2 |
| Nightingale, SD | 1 |
| Catanzaro, A | 3 |
| Galgiani, JN | 2 |
| Levine, BE | 1 |
| Sharkey-Mathis, PK | 1 |
| Fierer, J | 2 |
| Stevens, DA | 2 |
| Chapman, SW | 2 |
| Cloud, G | 1 |
| Paugam, A | 1 |
| Dupouy-Camet, J | 1 |
| Blanche, P | 1 |
| Gangneux, JP | 1 |
| Tourte-Schaefer, C | 1 |
| Sicard, D | 1 |
| Agresti, MG | 1 |
| de Bernardis, F | 1 |
| Mondello, F | 1 |
| Bellocco, R | 1 |
| Carosi, GP | 1 |
| Caputo, RM | 1 |
| Milazzo, F | 1 |
| Chiodo, F | 1 |
| Giannini, V | 1 |
| Minoli, L | 1 |
| Chubachi, A | 1 |
| Miura, I | 1 |
| Ohshima, A | 1 |
| Nishinari, T | 1 |
| Nimura, T | 1 |
| Niitsu, H | 1 |
| Miura, AB | 1 |
| Stengel, F | 1 |
| Robles-Soto, M | 1 |
| Galimberti, R | 1 |
| Suchil, P | 2 |
| Norris, S | 1 |
| Wheat, J | 1 |
| McKinsey, D | 1 |
| Lancaster, D | 1 |
| Katz, B | 1 |
| Black, J | 1 |
| Driks, M | 1 |
| Baker, R | 1 |
| Israel, K | 1 |
| Traeger, D | 1 |
| Millon, L | 1 |
| Manteaux, A | 1 |
| Reboux, G | 1 |
| Drobacheff, C | 1 |
| Monod, M | 1 |
| Barale, T | 1 |
| Michel-Briand, Y | 1 |
| Nelson, MR | 1 |
| Fisher, M | 1 |
| Cartledge, J | 1 |
| Rogers, T | 1 |
| Gazzard, BG | 1 |
| Laine, L | 2 |
| Dmitrieva, NV | 1 |
| Sokolova, EN | 1 |
| Makhova, EE | 1 |
| Petukhova, IN | 1 |
| Spitzer, ED | 1 |
| Spitzer, SG | 1 |
| Freundlich, LF | 1 |
| Casadevall, A | 1 |
| Marriott, DJ | 1 |
| Jones, PD | 1 |
| Hoy, JF | 1 |
| Speed, BR | 1 |
| Harkness, JL | 1 |
| Magee, JT | 1 |
| Philpot, C | 1 |
| Yang, J | 1 |
| Hosein, IK | 1 |
| Parente, F | 1 |
| Ardizzone, S | 1 |
| Cernuschi, M | 1 |
| Antinori, S | 1 |
| Esposito, R | 1 |
| Moroni, M | 1 |
| Lazzarin, A | 1 |
| Bianchi Porro, G | 1 |
| Redding, S | 1 |
| Smith, J | 1 |
| Farinacci, G | 1 |
| Rinaldi, M | 1 |
| Fothergill, A | 1 |
| Rhine-Chalberg, J | 1 |
| Pfaller, M | 1 |
| Zahid, MA | 1 |
| Klotz, SA | 1 |
| Hinthorn, DR | 1 |
| Martino, R | 1 |
| Nomdedéu, J | 1 |
| Altés, A | 1 |
| Sureda, A | 1 |
| Brunet, S | 1 |
| Martínez, C | 2 |
| Domingo-Albós, A | 1 |
| Cancelas, JA | 1 |
| Lopez, J | 1 |
| Cabezudo, E | 1 |
| Navas, E | 1 |
| Garcia Laraña, J | 1 |
| Jimenez Mena, M | 1 |
| Diz, P | 2 |
| Perez de Oteyza, J | 1 |
| Villalon, L | 1 |
| Sanchez-Sousa, A | 1 |
| Ocampo, A | 1 |
| Miralles, C | 1 |
| Otero, I | 1 |
| Iglesias, I | 1 |
| Graninger, W | 1 |
| Presteril, E | 1 |
| Schneeweiss, B | 1 |
| Teleky, B | 1 |
| Georgopoulos, A | 1 |
| Newton, JA | 1 |
| Tasker, SA | 1 |
| Bone, WD | 2 |
| Oldfield, EC | 2 |
| Olson, PE | 1 |
| Nguyen, MT | 1 |
| Wallace, MR | 1 |
| Wells, CJ | 1 |
| Leech, GJ | 1 |
| Lever, AM | 2 |
| Wansbrough-Jones, MH | 1 |
| Geletko, SM | 1 |
| Segarra, M | 1 |
| Mayer, KH | 1 |
| Fiore, TC | 1 |
| Bettencourt, FA | 1 |
| Flanigan, TP | 1 |
| Dudley, MN | 1 |
| Boerlin, P | 1 |
| Boerlin-Petzold, F | 1 |
| Goudet, J | 1 |
| Durussel, C | 1 |
| Pagani, JL | 1 |
| Chave, JP | 1 |
| Bille, J | 1 |
| Thompson, L | 1 |
| Pino, M | 1 |
| Castrillón, MA | 1 |
| Schenone, D | 1 |
| del Canto, E | 1 |
| Kunzelmann, V | 1 |
| Tietz, HJ | 1 |
| Rossner, D | 1 |
| Czaika, V | 1 |
| Hopp, M | 1 |
| Schmalreck, A | 1 |
| Sterry, W | 1 |
| Sullivan, D | 1 |
| Haynes, K | 1 |
| Moran, G | 1 |
| Shanley, D | 1 |
| Coleman, D | 1 |
| Montero-Gei, F | 2 |
| Robles-Soto, ME | 1 |
| Schlager, H | 1 |
| Christmas, NJ | 1 |
| Smiddy, WE | 1 |
| Maenza, JR | 1 |
| Merz, WG | 1 |
| Romagnoli, MJ | 1 |
| Keruly, JC | 1 |
| Moore, RD | 1 |
| Gallant, JE | 1 |
| Barantsevich, EP | 1 |
| Antonov, VV | 1 |
| Nizamutdinova, AS | 1 |
| Finkelstein, DM | 1 |
| Schoenfeld, DA | 1 |
| Stamenovic, E | 1 |
| Wilcox, CM | 1 |
| Darouiche, RO | 1 |
| Moskovitz, BL | 1 |
| Mallegol, I | 1 |
| Wu, J | 1 |
| Kaplan, B | 1 |
| Rabinerson, D | 1 |
| Gibor, Y | 1 |
| Lejko-Zupanc, T | 1 |
| Kozelj, M | 1 |
| Martin, CR | 1 |
| Gray, GC | 1 |
| Olson, P | 1 |
| Schillaci, RF | 1 |
| Burgaleta, C | 1 |
| Ainbinder, DJ | 1 |
| Parmley, VC | 1 |
| Mader, TH | 1 |
| Nelson, ML | 1 |
| Sharma, T | 1 |
| Parikh, S | 1 |
| Madhavan, HN | 1 |
| Badrinath, SS | 1 |
| Kern, W | 1 |
| Behre, G | 1 |
| Rudolf, T | 1 |
| Kerkhoff, A | 1 |
| Grote-Metke, A | 1 |
| Eimermacher, H | 1 |
| Kubica, U | 1 |
| Wörmann, B | 1 |
| Büchner, T | 1 |
| Hiddemann, W | 1 |
| Mahé, C | 1 |
| Revankar, SG | 1 |
| Kirkpatrick, WR | 1 |
| McAtee, RK | 1 |
| Dib, OP | 1 |
| Fothergill, AW | 1 |
| Redding, SW | 1 |
| Rinaldi, MG | 2 |
| Hilsenbeck, SG | 1 |
| Patterson, TF | 1 |
| Diaz-Guerra, TM | 1 |
| Valencia, E | 1 |
| Blomgren, J | 1 |
| Berggren, U | 1 |
| Jontell, M | 1 |
| Turner, DL | 1 |
| Johnson, SA | 1 |
| Rule, SA | 1 |
| Alonso, M | 1 |
| García, F | 1 |
| Mallolas, J | 1 |
| Soriano, A | 1 |
| Ortega, M | 1 |
| Miró, JM | 1 |
| Gatell, JM | 1 |
| Soriano, E | 1 |
| Robles, ME | 1 |
| Matthews, P | 1 |
| Drew, SV | 1 |
| Low, L | 1 |
| Shih, CC | 1 |
| Chen, YC | 1 |
| Chang, SC | 1 |
| Luh, KT | 1 |
| Hsieh, WC | 1 |
| Ringdahl, EN | 1 |
| Córdoba, S | 1 |
| Soria, M | 1 |
| Lucarini, M | 1 |
| Kaufman, S | 1 |
| Canteros, C | 1 |
| Cloud, GA | 2 |
| Johnson, RH | 1 |
| Williams, PL | 1 |
| Mirels, LF | 1 |
| Nassar, F | 1 |
| Lutz, JE | 1 |
| Sharkey, PK | 1 |
| Singh, VR | 1 |
| Larsen, RA | 5 |
| Delgado, KL | 1 |
| Flanigan, C | 1 |
| Badrul, B | 1 |
| Ruslan, G | 1 |
| Rodgers, P | 1 |
| Bassler, M | 1 |
| El-Din, SS | 1 |
| Reynolds, MT | 1 |
| Ashbee, HR | 1 |
| Barton, RC | 1 |
| Evans, EG | 1 |
| Rosen, EJ | 1 |
| Newlands, SD | 1 |
| Patel, J | 1 |
| Kalia, A | 1 |
| Friedman, NR | 1 |
| Samaranayake, YH | 1 |
| Samaranayake, LP | 1 |
| Tsang, PC | 1 |
| Wong, KH | 1 |
| Yeung, KW | 1 |
| Kapernick, PS | 1 |
| Zervos, M | 1 |
| Reed, BD | 1 |
| Hooton, T | 1 |
| Soper, D | 1 |
| Heine, MW | 1 |
| Willems, J | 1 |
| Panzer, H | 1 |
| Wittes, H | 1 |
| Brent, NB | 1 |
| Brizendine, E | 1 |
| Hafner, R | 1 |
| Kaltenbach, G | 1 |
| Vogel, T | 1 |
| Noblet-Dick, M | 1 |
| Heitz, D | 1 |
| Berthel, M | 1 |
| Kuntzmann, F | 1 |
| Cooper, CM | 1 |
| Gordon, DL | 1 |
| Reid, C | 1 |
| Philpot, CR | 1 |
| Coldiron, B | 1 |
| Saag, MS | 1 |
| Meyer, RD | 1 |
| Jacobson, JM | 1 |
| Graybill, JR | 1 |
| Sugar, AM | 1 |
| McAuliffe, VJ | 1 |
| Follansbee, SE | 1 |
| Wells, C | 1 |
| Haglund, LA | 1 |
| Greenfield, RA | 1 |
| Lange, JM | 1 |
| Reiss, P | 1 |
| Glück, T | 1 |
| Weber, P | 1 |
| Wiedmann, KH | 1 |
| Just-Nübling, G | 1 |
| Gentschew, G | 1 |
| Meissner, K | 1 |
| Odewald, J | 1 |
| Staszewski, S | 1 |
| Helm, EB | 1 |
| Stille, W | 1 |
| Bozzette, SA | 2 |
| Chiu, J | 3 |
| Leal, MA | 3 |
| Tilles, JG | 1 |
| Richman, DD | 2 |
| Leedom, JM | 1 |
| McCutchan, JA | 3 |
| Lim, SG | 1 |
| Lee, CA | 1 |
| Hales, M | 1 |
| O'Doherty, M | 1 |
| Winter, M | 1 |
| Kernoff, PB | 1 |
| De Wit, S | 2 |
| Urbain, D | 1 |
| Rahir, F | 1 |
| Weerts, D | 2 |
| Clumeck, N | 2 |
| Costa, AR | 1 |
| Porto, E | 1 |
| Pegas, JR | 1 |
| dos Reis, VM | 1 |
| Pires, MC | 1 |
| Lacaz, Cda S | 1 |
| Rodrigues, MC | 1 |
| Müller, H | 1 |
| Cucé, LC | 1 |
| Jacobsen, J | 1 |
| Rothman, P | 1 |
| Tilles, J | 1 |
| Martínez, A | 1 |
| Salavert, M | 1 |
| Nieto, A | 1 |
| Navarro, V | 1 |
| Medina, E | 1 |
| Carrasco, R | 1 |
| Leen, CL | 1 |
| Dunbar, EM | 1 |
| Ellis, ME | 1 |
| Mandal, BK | 1 |
| King, C | 1 |
| Finley, R | 1 |
| Friedman, PJ | 1 |
| Moncino, MD | 1 |
| Gutman, LT | 1 |
| Bozzette, S | 1 |
| Goossens, H | 1 |
| Kutzer, E | 1 |
| Oittner, R | 1 |
| Leodolter, S | 1 |
| Brammer, KW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of VT-1161 Oral Tablets in the Treatment of Patients With Recurrent Vulvovaginal Candidiasis[NCT02267382] | Phase 2 | 254 participants (Actual) | Interventional | 2015-02-10 | Completed | ||
| A Phase I/II Dose-Finding Study of High-Dose Fluconazole Treatment in AIDS-Associated Cryptococcal Meningitis[NCT00885703] | Phase 1/Phase 2 | 168 participants (Actual) | Interventional | 2010-04-16 | Completed | ||
| An Open Multicenter Trial of Fluconazole Oral Suspension in the Treatment of Esophageal Candidiasis in Immunocompromised Patients[NCT00002339] | Phase 3 | 100 participants | Interventional | Completed | |||
| A Phase IIa Randomized, Active-controlled, Double-blind, Dose-escalation Study in Patients With Vulvovaginal Candidiasis to Evaluate Dose Response Relationship of Clinical Efficacy, Safety and Tolerability of Topically Administered ProF-001[NCT03115073] | Phase 2/Phase 3 | 84 participants (Actual) | Interventional | 2017-04-04 | Completed | ||
| Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome[NCT00002074] | 0 participants | Interventional | Completed | ||||
| Comparison of Fluconazole (UK-49,858) and Amphotericin B for Maintenance Treatment of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome[NCT00001017] | Phase 3 | 330 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"A culture-verified acute VVC episode was defined as a positive fungal culture for Candida species associated with a clinical signs and symptoms score of ≥3. To calculate the 'signs and symptoms' score, each vulvovaginal sign (erythema, edema, excoriation) and symptom (itching, burning, irritation) was scored using the following scale, with higher scores indicating a worse outcome.~0 = none (complete absence of any sign or symptom)~= mild (slight)~= moderate (definitely present)~= severe (marked, intense)" (NCT02267382)
Timeframe: 48 Weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| VT-1161 Low-dose 3-month | 2 |
| VT-1161 Low-dose 6-month | 3 |
| VT-1161 High-dose 3-month | 0 |
| VT-1161 High-dose 24-week | 2 |
| Placebo | 24 |
"Change in quantitative CSF (cerebrospinal fluid) cultures.~Note: No further CSF specimens are drawn following a negative culture. Thus, only week 2 CSF cultures are considered in this analysis." (NCT00885703)
Timeframe: Entry and Week 2
| Intervention | Log10 CFU/mL (Median) |
|---|---|
| Fluconazole 1200mg | -1.51 |
| Fluconazole 1600mg | -2.51 |
| Fluconazole 2000mg | -1.78 |
| Ampho B | -2.81 |
Kaplan Meier Proportion of participants who died over study with 90% Confidence Intervals. (NCT00885703)
Timeframe: Measured from study entry through Week 24
| Intervention | proportion of participants (Number) |
|---|---|
| Fluconazole 1200mg | 0.41 |
| Fluconazole 1600mg | 0.30 |
| Fluconazole 2000mg | 0.36 |
| Ampho B | 0.24 |
Duration of first hospitalization in days starting at entry in safety population. (NCT00885703)
Timeframe: Measured from study entry through Week 10
| Intervention | Days (Median) |
|---|---|
| Fluconazole 1200mg | 15 |
| Fluconazole 1600mg | 17.5 |
| Fluconazole 2000mg | 18 |
| Ampho B | 18.5 |
"Discontinuation of study-provided high dose fluconazole at or by week 10 Discontinuation of study-provided ampho B at or by week 2~Discontinuation includes discontinuing for any reason, including progression of symptoms, death, etc." (NCT00885703)
Timeframe: Measured from study entry through Week10
| Intervention | Participants (Count of Participants) |
|---|---|
| Stage 1, Fluconazole 1200mg | 14 |
| Stage 1, Fluconazole 1600mg | 11 |
| Stage 1, Fluconazole 2000mg | 11 |
| Stage 1, Ampho B | 6 |
| Stage 2, Fluconazole 1600mg | 12 |
| Stage 2, Fluconazole 2000mg | 13 |
| Stage 2, Ampho B | 6 |
Number of participants who were diagnosed with CNS immune reconstitution inflammatory syndrome (IRIS) (NCT00885703)
Timeframe: Measured from study entry through Week 24
| Intervention | Participants (Count of Participants) |
|---|---|
| Fluconazole 1200mg | 1 |
| Fluconazole 1600mg | 0 |
| Fluconazole 2000mg | 0 |
| Ampho B | 1 |
"Progression of symptoms is defined as:~Died (including early deaths)~Discontinued Fluconazole and started ampho B~Had a positive cryptococcal culture at week 10~Microbiological Failure (i.e., relapse of CM)~Complication of CM (e.g., obstructive hydrocephalus or vascular complications such as venous or arterial thrombosis)~CM IRIS causing increased inflammation after ART exposure~New CNS Ol (e.g., toxoplasmosis, PML, CNS lymphoma)~Possibly related to CM but mechanism indeterminate~Other defined complication unrelated to CM" (NCT00885703)
Timeframe: Measured from study entry through Week 24
| Intervention | Participants (Count of Participants) |
|---|---|
| Fluconazole 1200mg | 14 |
| Fluconazole 1600mg | 21 |
| Fluconazole 2000mg | 24 |
| Ampho B | 19 |
"Occurrence of grade 3 (severe) and 4 (life-threatening) sign and symptoms events (as defined by FSTRF Appendix 29)~Occurrence of grade 3 (severe) and 4 (life-threatening) laboratory events (as defined by FSTRF Appendix 76)~See DAIDS AE Grading table V1.0" (NCT00885703)
Timeframe: Measured from study entry through Week 24
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Sign/Symptom Events | Laboratory Events | |
| Ampho B | 24 | 30 |
| Fluconazole 1200mg | 16 | 12 |
| Fluconazole 1600mg | 23 | 27 |
| Fluconazole 2000mg | 32 | 26 |
"Functional assessment of work status and ability. Consists of 2 measures: 1) Does participants have full time work status 2) Does participant have functional ability to work.~The measure from 6 week before enrollment will be referred to as 'baseline'." (NCT00885703)
Timeframe: Measured 6 weeks before enrollment, at study entry, at Week 10, and at Week 24
| Intervention | Participants (Count of Participants) | |||||||
|---|---|---|---|---|---|---|---|---|
| Baseline Had full time work status | Entry Had full time work status | Week 10 Had full time work status | Week 24 Had full time work status | Baseline Had functional ability to work | Entry Had functional ability to work | Week 10 Had functional ability to work | Week 24 Had functional ability to work | |
| Ampho B | 42 | 9 | 13 | 22 | 38 | 7 | 15 | 24 |
| Fluconazole 1200mg | 18 | 3 | 3 | 7 | 16 | 1 | 4 | 7 |
| Fluconazole 1600mg | 41 | 9 | 16 | 18 | 41 | 8 | 18 | 19 |
| Fluconazole 2000mg | 36 | 8 | 9 | 17 | 32 | 3 | 9 | 16 |
Count of participants who were CM negative (had no cryptococcal growth), CM negative after switching treatment (switched from Fluconazole to Ampho B or vice versa and later became CM negative), CM positive, Died, Lost to follow-up. Note: CM positive means continued to have cryptococcal growth. (NCT00885703)
Timeframe: At entry, Week 2, and Week 10
| Intervention | Participants (Count of Participants) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Week 072337496 | Week 072337498 | Week 072337499 | Week 072337497 | Week 272337496 | Week 272337497 | Week 272337498 | Week 272337499 | Week 1072337496 | Week 1072337497 | Week 1072337498 | Week 1072337499 | |||||||||||||||||||||||||||||||||||||||||||||||||
| CM Negative after switching treatment | Died | Lost to Follow-up | CM Positive | CM Negative | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 1200mg | 20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 1600mg | 45 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 2000mg | 43 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ampho B | 46 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 1200mg | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 2000mg | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ampho B | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 1600mg | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 1200mg | 12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 1600mg | 27 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 2000mg | 27 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ampho B | 29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 1600mg | 12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 2000mg | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ampho B | 13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 1200mg | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 1600mg | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 2000mg | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ampho B | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 1200mg | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 1600mg | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 2000mg | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ampho B | 2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 1200mg | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 1600mg | 24 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 2000mg | 22 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ampho B | 37 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 1200mg | 1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 2000mg | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 1600mg | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 2000mg | 12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ampho B | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 1600mg | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fluconazole 2000mg | 1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ampho B | 1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Results from Glasgow Coma Score, which provides assessment of impairment of conscious level in response to defined stimuli. Min score of 0 and max score of 15 (no mental impairment). (NCT00885703)
Timeframe: Measured at study entry, Week 2, and Week 10
| Intervention | Participants (Count of Participants) | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Week 072337496 | Week 072337497 | Week 072337498 | Week 072337499 | Week 272337496 | Week 272337497 | Week 272337498 | Week 272337499 | Week 1072337497 | Week 1072337498 | Week 1072337496 | Week 1072337499 | |||||||||||||
| Score = 15 | Score < 15 | |||||||||||||||||||||||
| Fluconazole 1200mg | 5 | |||||||||||||||||||||||
| Fluconazole 1600mg | 5 | |||||||||||||||||||||||
| Fluconazole 2000mg | 5 | |||||||||||||||||||||||
| Ampho B | 1 | |||||||||||||||||||||||
| Fluconazole 1200mg | 17 | |||||||||||||||||||||||
| Fluconazole 1600mg | 45 | |||||||||||||||||||||||
| Fluconazole 2000mg | 42 | |||||||||||||||||||||||
| Ampho B | 47 | |||||||||||||||||||||||
| Fluconazole 1200mg | 2 | |||||||||||||||||||||||
| Fluconazole 1600mg | 4 | |||||||||||||||||||||||
| Fluconazole 2000mg | 4 | |||||||||||||||||||||||
| Ampho B | 5 | |||||||||||||||||||||||
| Fluconazole 1200mg | 15 | |||||||||||||||||||||||
| Fluconazole 1600mg | 38 | |||||||||||||||||||||||
| Fluconazole 2000mg | 36 | |||||||||||||||||||||||
| Ampho B | 38 | |||||||||||||||||||||||
| Fluconazole 1200mg | 1 | |||||||||||||||||||||||
| Fluconazole 1600mg | 1 | |||||||||||||||||||||||
| Fluconazole 2000mg | 1 | |||||||||||||||||||||||
| Ampho B | 0 | |||||||||||||||||||||||
| Fluconazole 1200mg | 11 | |||||||||||||||||||||||
| Fluconazole 1600mg | 33 | |||||||||||||||||||||||
| Fluconazole 2000mg | 26 | |||||||||||||||||||||||
| Ampho B | 34 | |||||||||||||||||||||||
17 reviews available for fluconazole and Recrudescence
| Article | Year |
|---|---|
Systemic antifungal therapy for oesophageal candidiasis - systematic review and meta-analysis of randomized controlled trials.
Topics: Antifungal Agents; Azoles; Candidiasis; Echinocandins; Esophagitis; Fluconazole; Humans; Randomized | 2022 |
Interplay of the microbiome and antifungal therapy in recurrent vulvovaginal candidiasis (RVVC): A narrative review.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; | 2023 |
Probiotics for vulvovaginal candidiasis in non-pregnant women.
Topics: Administration, Intravaginal; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Fl | 2017 |
A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; D | 2018 |
Combined systemic (fluconazole) and topical (metronidazole + clotrimazole) therapy for a new approach to the treatment and prophylaxis of recurrent candidiasis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrim | 2019 |
Coccidioidomycosis of the genitourinary tract: a case report and discussion.
Topics: Antifungal Agents; Biopsy, Needle; Coccidioides; Coccidioidomycosis; Diagnosis, Differential; Flucon | 2014 |
Intracranial Fungal Granulomas: A Single Institutional Clinicopathologic Study of 66 Patients and Review of the Literature.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brain; Central Nervous System Fungal Inf | 2015 |
[Oropharyngeal candidiasis in the practical work of the otorhinolaryngologist].
Topics: Administration, Topical; Antifungal Agents; Candida albicans; Candidiasis; Diagnosis, Oral; Drug Res | 2010 |
The role of fluconazole in the treatment of Candida endocarditis: a meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida albicans; Candidemia; Candidiasis; Dose-R | 2011 |
[Disseminated histoplasmosis and AIDS in an Argentine hospital: clinical manifestations, diagnosis and treatment].
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argenti | 2004 |
Recurrent tinea versicolor: treatment with itraconazole or fluconazole?
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Humans; Itraconazole; Recurrence; Tinea Versic | 2007 |
Resistant candidiasis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Mic | 1994 |
The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Cryptococcosis; Fluconazole; Fungemia; Humans | 1994 |
[Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Candidia | 1995 |
Recurrent vaginal thrush and soreness.
Topics: Adult; Anti-Infective Agents, Local; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Dia | 1999 |
Treatment of recurrent vulvovaginal candidiasis.
Topics: Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Clotrimazole; Drug Interactions; Female; | 2000 |
Treating onychomycosis.
Topics: Adult; Antifungal Agents; Child; Clinical Trials as Topic; Combined Modality Therapy; Diagnosis, Dif | 2001 |
34 trials available for fluconazole and Recrudescence
| Article | Year |
|---|---|
Quality of life in women with chronic recurrent vulvovaginal candidosis: A sub-analysis of the prospective multicentre phase IIb/III Prof-001 study.
Topics: Candidiasis, Chronic Mucocutaneous; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Male; Pr | 2023 |
A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis.
Topics: 14-alpha Demethylase Inhibitors; Administration, Oral; Adult; Antifungal Agents; Candidiasis, Vulvov | 2018 |
Sexual behaviour and extra-genital colonisation in women treated for recurrent Candida vulvo-vaginitis.
Topics: Adult; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Recurrenc | 2018 |
Dermasilk® briefs in recurrent vulvovaginal candidosis. An alternative option in long-lasting disease.
Topics: Candidiasis, Vulvovaginal; Double-Blind Method; Fluconazole; Humans; Recurrence | 2013 |
Single-dose oral fluconazole versus topical clotrimazole in patients with pityriasis versicolor: A double-blind randomized controlled trial.
Topics: Adult; Antifungal Agents; Clinical Protocols; Clotrimazole; Double-Blind Method; Female; Fluconazole | 2010 |
Fluconazole response patterns in HIV-infected patients with oropharyngeal candidiasis.
Topics: Candida albicans; Candidiasis, Oral; CD4 Lymphocyte Count; Colony Count, Microbial; Fluconazole; HIV | 1995 |
Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group.
Topics: Administration, Oral; Adolescent; Candidiasis, Oral; Child; Child, Preschool; Double-Blind Method; D | 1995 |
Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Fluconazole Vaginitis Study Group.
Topics: Acute Disease; Administration, Oral; Administration, Topical; Adolescent; Adult; Candidiasis, Vulvov | 1995 |
Initial therapy for acquired immunodeficiency syndrome-associated cryptococcosis with fluconazole.
Topics: Adult; AIDS-Related Opportunistic Infections; Cryptococcosis; Female; Fluconazole; Humans; Male; Rec | 1995 |
Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Coccidioidomycosis; Fluconazole; Humans; Lung Disea | 1995 |
Clinical and mycological evaluation of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS patients. An open, multicenter study.
Topics: Adult; AIDS-Related Opportunistic Infections; Antigens, Fungal; Candida albicans; Candidiasis; Esoph | 1994 |
Fluconazole versus ketoconazole in the treatment of dermatophytoses and cutaneous candidiasis.
Topics: Adult; Candida; Candidiasis, Cutaneous; Double-Blind Method; Female; Fluconazole; Follow-Up Studies; | 1994 |
[A trial of the use of diflucan (fluconazole) in patients with vaginal candidiasis].
Topics: Administration, Oral; Adult; Candida albicans; Candidiasis, Vulvovaginal; Female; Fluconazole; Gardn | 1993 |
Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV-infected patients. A double-blind placebo-controlled study.
Topics: Adult; Alkaline Phosphatase; Candidiasis, Oral; Double-Blind Method; Drug Administration Schedule; F | 1993 |
Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study.
Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis; Esophagitis; Female; Fluconazole; Follow- | 1994 |
Electronic compliance assessment of antifungal prophylaxis for human immunodeficiency virus-infected women.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Chronic Mucocutaneous; | 1996 |
[Prerequisites for effective therapy of chronic recurrent vaginal candidiasis].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candida albicans; Candidiasis, Vulvovaginal; Ch | 1996 |
Fluconazole in the treatment of severe onychomycosis.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antifungal Agents; Arthrodermataceae; Female; Fluconazole; | 1996 |
A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; Double-Blind Method; Esophageal Disease | 1997 |
Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Amphotericin B; Antibiotic Prophylaxis | 1998 |
A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Drug Resistance, | 1998 |
Change in fluconazole susceptibility patterns and genetic relationship among oral Candida albicans isolates.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; DNA, | 1998 |
Fluconazole versus nystatin in the treatment of oral candidosis.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Candidiasis, Oral; Capsules; Dentures; Erythem | 1998 |
Fluconazole vs. itraconazole in the treatment of tinea versicolor.
Topics: Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluconazo | 1999 |
Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Antifungal Agents; Bon | 2000 |
Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole.
Topics: Adult; Antifungal Agents; Candida; Candida albicans; Candidiasis, Vulvovaginal; Double-Blind Method; | 2001 |
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amphotericin B; Female; Fluconazole | 1992 |
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amphotericin B; Female; Fluconazole | 1992 |
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amphotericin B; Female; Fluconazole | 1992 |
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amphotericin B; Female; Fluconazole | 1992 |
Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients.
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Chronic Disease; Drug Administration Schedule | 1991 |
Fluconazole for oropharyngeal candidiasis in anti-HIV positive haemophiliacs.
Topics: Adolescent; Adult; Aged; Candidiasis; Candidiasis, Oral; Child; Double-Blind Method; Female; Flucona | 1991 |
Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Alanine Transaminase; Asparta | 1991 |
A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Cryptococcosis; Double-Blind Method; Drug Evaluatio | 1991 |
Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Candidiasis, Oral; Clinical Trials | 1990 |
Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; AIDS-Related Complex; Candidi | 1989 |
A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis; report of a double-blind multicentre trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Candidiasis, Vulvovaginal; Clinica | 1988 |
144 other studies available for fluconazole and Recrudescence
| Article | Year |
|---|---|
Oteseconazole: an advance in treatment of recurrent vulvovaginal candidiasis.
Topics: Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Recurre | 2021 |
Prognosis and Long-Term Outcome of Women With Idiopathic Recurrent Vulvovaginal Candidiasis Caused by Candida albicans.
Topics: Adolescent; Adult; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Drug Resistance, | 2020 |
Vaginal pH and microbiota during fluconazole maintenance treatment for recurrent vulvovaginal candidosis (RVVC).
Topics: Acute Disease; Adolescent; Adult; Antifungal Agents; Bacteria; Candida; Candidiasis, Vulvovaginal; D | 2020 |
Case Report: A Case of Severe Cryptococcal Immune Reconstitution Inflammatory Syndrome Presenting with Brain and Intradural Abscesses in an HIV Patient.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Anti-Inflammatory Agents; Anti-Retroviral Agents | 2020 |
Bicavitary eosinophilic effusion in a dog with coccidioidomycosis.
Topics: Animals; Antifungal Agents; Ascitic Fluid; Bone Diseases; Coccidioides; Coccidioidomycosis; Dog Dise | 2020 |
Disseminated Lomentospora prolificans infection in a patient on idelalisib-rituximab therapy for relapsed chronic lymphocytic leukaemia.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Resistance | 2020 |
Non-response to fluconazole maintenance treatment (ReCiDiF regimen) for recurrent vulvovaginal candidosis is not related to impaired glucose metabolism.
Topics: Adult; Antifungal Agents; Blood Glucose; Body Mass Index; Candidiasis, Vulvovaginal; Diabetes Compli | 2017 |
Tinea Faciei: Challenges in the Diagnosis.
Topics: Administration, Oral; Antifungal Agents; Child, Preschool; Facial Dermatoses; Fluconazole; Griseoful | 2017 |
[A case of coccidioidomycosis in Turkey imported from the United States of America].
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Antifungal Agents; Arizona; Coccidioides; Cocc | 2017 |
Fluconazole Non-susceptible Cryptococcus neoformans, Relapsing/Refractory Cryptococcosis and Long-term Use of Liposomal Amphotericin B in an AIDS Patient.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoforman | 2017 |
In vitro activity of isavuconazole against fluconazole-resistant isolates of Histoplasma capsulatum.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Histoplasma; Histoplasmosis; Humans; Microb | 2018 |
Is non-response to fluconazole maintenance therapy for recurrent Candida vaginitis related to sensitization to atopic reactions?
Topics: Adult; Candida albicans; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Hypersensitivity, I | 2018 |
Intrathecal spinal abscesses due to
Topics: Abscess; Adult; Antifungal Agents; Candida albicans; Candidiasis; Drainage; Fluconazole; Humans; Imm | 2018 |
Cryptococcoma of a transplanted kidney in a patient presenting with recurrent urinary tract infection: a case report.
Topics: Adult; Antifungal Agents; Bacterial Infections; Biopsy; Coinfection; Cryptococcosis; Cryptococcus ne | 2018 |
Long-Term Outcomes of Women With Recurrent Vulvovaginal Candidiasis After a Course of Maintenance Antifungal Therapy.
Topics: Adult; Aged; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Female; Fluconazole; Fo | 2018 |
A rare case of acute pancreatitis caused by Candida Albicans.
Topics: Abdominal Pain; Acute Disease; Antifungal Agents; Candida albicans; Candidiasis; Combined Modality T | 2019 |
Is multiple-site colonization with Candida spp. related to inadequate response to individualized fluconazole maintenance therapy in women with recurrent Candida vulvovaginitis?
Topics: Adult; Aged; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; | 2018 |
Fixed drug eruption caused by fluconazole-An underdiagnosed but recurrent problem.
Topics: Aged; Antifungal Agents; Drug Eruptions; Female; Fluconazole; Humans; Intradermal Tests; Patch Tests | 2019 |
Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review protocol.
Topics: Administration, Intravaginal; Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Dr | 2019 |
Infectious endocarditis caused by Candida glabrata: evidence of in vivo development of echinocandin resistance.
Topics: Aged, 80 and over; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Echino | 2019 |
Pityriasis versicolor: a case of resistance to treatment.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconaz | 2014 |
Successful treatment of recurrent candidemia due to candidal thrombophlebitis associated with a central venous catheter using a combination of fosfluconazole and micafungin.
Topics: Aged, 80 and over; Antifungal Agents; Candidemia; Catheter-Related Infections; Central Venous Cathet | 2013 |
Scedosporium prolificans fungaemia in a patient with acute lymphoblastic leukaemia.
Topics: Allografts; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone | 2013 |
Recurrence of coccidioidal meningitis after discontinuation of fluconazole.
Topics: Antifungal Agents; Brain; Coccidioidomycosis; Female; Fluconazole; Humans; Magnetic Resonance Imagin | 2013 |
Antifungal step-down therapy based on hospital intravenous to oral switch policy and susceptibility testing in adult patients with candidaemia: a single centre experience.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Antifungal Agents; Candidemia; Drug Administratio | 2014 |
Prevalence of Candida albicans and non-albicans isolates from vaginal secretions: comparative evaluation of colonization, vaginal candidiasis and recurrent vaginal candidiasis in diabetic and non-diabetic women.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Brazil; Candida; Candida albicans; Candidiasis, Vulvovag | 2014 |
Recurrent arthritis by Candida glabrata, a diagnostic and therapeutic challenge.
Topics: Adult; Antifungal Agents; Arthritis; Candida glabrata; Candidiasis; Fluconazole; Humans; Male; Recur | 2014 |
Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Antifungal Agents; Candida al | 2015 |
Cryptococcal meningoencephalitis relapse after an eight-year delay: an interplay of infection and immune reconstitution.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, H | 2015 |
Utility of in-house fluconazole disk diffusion susceptibility testing in the treatment of candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidemia; Cohort Studies; Disk Diff | 2016 |
Candida duobushaemulonii: an emerging rare pathogenic yeast isolated from recurrent vulvovaginal candidiasis in Brazil.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluc | 2016 |
[Polymorphic lesions of cutaneous leishmaniasis revealing human immunodeficiency virus infection].
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiprotozoal Agents; Antiretroviral Therapy | 2016 |
A Case Report of Penile Infection Caused by Fluconazole- and Terbinafine-Resistant Candida albicans.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis, Chronic Mucocutaneous; Drug Resistance, Fun | 2017 |
Thalidomide for steroid-dependent chronic disseminated candidiasis after stem cell transplantation: A case report.
Topics: Antifungal Agents; Bone Marrow Transplantation; Candida albicans; Candidiasis; Chronic Disease; Fluc | 2017 |
Elevated nitric oxide in recurrent vulvovaginal candidiasis - association with clinical findings.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Case-Control Studies; Female; Fluco | 2017 |
Mannose-binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginal candidiasis.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Case-Control Studies; Codon; Drug Resistance; F | 2008 |
A young woman with recurrent vesicles on the lower lip: fixed drug eruption mimicking herpes simplex.
Topics: Adult; Antifungal Agents; Diagnosis, Differential; Drug Eruptions; Female; Fluconazole; Herpes Simpl | 2008 |
[Cryptococcal meningoencephalitis related to HIV infection with resistance to fluconazole, relapse, and IRIS].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Cryptococcus neofo | 2009 |
An unusual cause of haemoptysis and headache: cryptococcosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Diagnosis, Differential; Fluconazole; Head | 2008 |
Recurrence of cryptococcal meningitis in HIV-infected patients following immune reconstitution.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV Agents; Antifunga | 2009 |
[Candida-induced recurrent peritonitis after peritoneal catheter reinsertion].
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Catheter-Related Infections; Device Rem | 2009 |
Fluconazole-induced recurrent ventricular fibrillation leading to multiple cardiac arrests.
Topics: Adult; Antifungal Agents; Diabetic Ketoacidosis; Female; Fluconazole; Heart Arrest; Humans; Hypocalc | 2009 |
Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Fema | 2009 |
Trends in frequency and in vitro antifungal susceptibility patterns of Candida isolates from women attending the STD outpatients clinic of a tertiary care hospital in Northern Italy during the years 2002-2007.
Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; | 2009 |
Fungal laryngitis.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Antifungal Agents; Candidiasis; Disease Suscept | 2009 |
Epstein-Barr virus and parvovirus B19 coinfection in a Crohn's disease patient under azathioprine.
Topics: Antibodies, Monoclonal; Azathioprine; Crohn Disease; Epstein-Barr Virus Infections; Fluconazole; Gra | 2010 |
Intraventricular fungus ball: a unique manifestation of refractory intracranial candidiasis in an immunocompetent neonate.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Brain Diseases; Candidiasis; Caspofungin; E | 2009 |
Candida parapsilosis meningitis associated with shunt infection in an adult male.
Topics: Amphotericin B; Antifungal Agents; Brain Abscess; Candida; Candidiasis; Drainage; Fluconazole; Flucy | 2010 |
Biofilm formation on intrauterine devices in patients with recurrent vulvovaginal candidiasis.
Topics: Adult; Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Candidiasis, Vulvovaginal; Fem | 2010 |
Explosive nasofacial cryptococosis.
Topics: Acids; Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; An | 2010 |
Symptomatic relapse of HIV-associated cryptococcal meningitis in South Africa: the role of inadequate secondary prophylaxis.
Topics: Adult; Antifungal Agents; Female; Fluconazole; HIV Infections; Humans; Male; Meningitis, Cryptococca | 2010 |
Recurrent vulvovaginal candidosis: focus on the vulva.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Biopsy; Candida albicans; Candidia | 2011 |
FPIN’s clinical inquiries: treatment of recurrent vulvovaginal candidiasis.
Topics: Administration, Intravaginal; Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Cl | 2011 |
Recurrent Saccharomyces cerevisiae fungemia in an otherwise healthy patient.
Topics: Abdominal Pain; Adult; Amphotericin B; Antifungal Agents; Chills; Diagnosis, Differential; Female; F | 2011 |
Otomycosis in Shanghai: aetiology, clinical features and therapy.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child | 2012 |
Invasive fungal bezoar requiring partial cystectomy.
Topics: Aged; Amphotericin B; Antifungal Agents; Bezoars; Candidiasis; Combined Modality Therapy; Cystectomy | 2012 |
Oral candidosis: characterization of a sample of recurrent infections and study of resistance determinants.
Topics: Adult; Aged; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida alb | 2011 |
Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antifungal Agents; Boric Acids; Candida albicans; Candid | 2012 |
Disseminated Cryptococcus with ocular cryptococcoma in a human immunodeficiency virus-negative patient.
Topics: Amphotericin B; Anemia, Hemolytic, Autoimmune; Antifungal Agents; Cryptococcosis; Cryptococcus; Drug | 2012 |
Recurrent fungal iris granuloma in a 10-year-old child.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Drug Therapy, Combination; Eye Infec | 2012 |
[Efficacy of voriconazole treatment in chronic vulvovaginal candidosis due to Candida glabrata].
Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis, Vulvovaginal; Cesarean Section; Drug Evalua | 2013 |
Challenges in diagnosis and management of Cryptococcal immune reconstitution inflammatory syndrome (IRIS) in resource limited settings.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Cr | 2012 |
Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Antiretroviral Therapy, Highly Active; | 2002 |
Two cases of Aspergillus sinusitis with bone destruction.
Topics: Aged; Aspergillosis; Cranial Nerve Diseases; Disease Progression; Ethmoid Sinus; Ethmoid Sinusitis; | 2003 |
Relapse of coccidioidomycosis despite immune reconstitution after fluconazole secondary prophylaxis in a patient with AIDS.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Coccidioidomycosis; Drug Therapy, Combinat | 2003 |
Clinical resistance of recurrent Candida albicans vulvovaginitis to fluconazole in the presence and absence of in vitro resistance.
Topics: Adolescent; Adult; Antifungal Agents; Candida albicans; Candidiasis; Cohort Studies; Drug Resistance | 2003 |
Aspergillosis: a rare case of secondary delayed mandibular involvement.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Female; Fluconazole; Humans; Mandibular Dis | 2003 |
Cryptococcosis of the central nervous system in a dog.
Topics: Animals; Antifungal Agents; Central Nervous System; Central Nervous System Fungal Infections; Crypto | 2003 |
Successful treatment of mucormycosis peritonitis with liposomal amphotericin B in a patient on long-term peritoneal dialysis.
Topics: Abdominal Abscess; Amphotericin B; Antifungal Agents; Bacteroides fragilis; Combined Modality Therap | 2003 |
G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amino Acid Sequence; Amino Acid Substitution; Antifungal | 2003 |
Recurrent scleral abscess after uncomplicated cataract extraction.
Topics: Abscess; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Cataract Extraction; Drug Therapy, Co | 2004 |
Recurrent Candida tropicalis meningitis.
Topics: Antifungal Agents; Candida tropicalis; Candidiasis; Craniotomy; Fluconazole; Humans; Male; Meningiti | 2005 |
[Meningeal cryptococcosis as a sign of immune reconstitution syndrome].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV Agents; Antifungal Agents; An | 2005 |
Subcutaneous phaeohyphomycosis caused by Cladophialophora bantiana.
Topics: Adult; Antifungal Agents; Ascomycota; Biopsy; Dermatomycoses; Female; Fluconazole; Glucocorticoids; | 2005 |
Post-menopausal recurrent vaginal candidiasis: effect of hysterectomy on response to treatment, type of colonization and recurrence rates post-treatment.
Topics: Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Case-Control Studies; Cohort Studies | 2005 |
Successful treatment of refractory recurrent vaginal candidiasis with cetirizine plus fluconazole.
Topics: Adult; Anti-Allergic Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Cetirizine; Female; Fluco | 2005 |
[A man with Candida pyopneumopericarditis and cardiac tamponade in conjunction with gastric tube infection].
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Cardiac Tamponade; Esophageal Neoplasms; Esophagus | 2005 |
Long term control of hypercortisolism with fluconazole: case report and in vitro studies.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aged, 80 and over; Antifungal Agents; Cell Line, Tu | 2006 |
Acute respiratory distress syndrome with transiently impaired left ventricular function and Torsades de Pointes arrhythmia unmasking congenital long QT syndrome in a 25-yr-old woman.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Echocardiography; ERG1 Potassium Channel; Erythromy | 2006 |
Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; F | 2006 |
Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Antigens, Fungal; Antiretroviral Th | 2006 |
A case of malignant otitis externa caused by Candida glabrata in a patient receiving haemodialysis.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida glabrata; Candidiasis; Fluconazole; Gallium Radiois | 2007 |
Relapsing Rhodococcus equi infection in a heart transplant recipient successfully treated with long-term linezolid.
Topics: Acetamides; Actinomycetales Infections; Anti-Bacterial Agents; Cryptococcosis; Cryptococcus neoforma | 2008 |
An unusual case of stroke and fevers in a traveler returning from Arizona.
Topics: Aged; Antifungal Agents; Arizona; Cerebral Infarction; Coccidiosis; Female; Fever; Fluconazole; Huma | 2008 |
Chronic fungal vaginitis: the value of cultures.
Topics: Candida; Candida albicans; Candidiasis, Vulvovaginal; Chronic Disease; Female; Fluconazole; Humans; | 1995 |
Fulminant cryptococcal infections in HIV-infected patients on oral fluconazole.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Candidiasis, Oral; Cryptococcosi | 1995 |
Comparison of different treatment methods for localized and generalized simple denture stomatitis.
Topics: Administration, Oral; Candida albicans; Candidiasis, Oral; Chlorhexidine; Colony Count, Microbial; D | 1995 |
[Severe pulmonary and meningeal cryptococcosis in an immunocompetent Cambodian].
Topics: Cambodia; Combined Modality Therapy; Cryptococcosis; Diagnosis, Differential; Fluconazole; Humans; I | 1995 |
[Fungemia caused by Candida krusei in a female patient with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candida; Candidiasis, Oral; Female; Fluco | 1994 |
[Fluconazole sensitivity of Candida strains in vitro in the microdilution test and agar diffusion test].
Topics: AIDS-Related Opportunistic Infections; Candida; Candidiasis, Oral; Fluconazole; Humans; Immunodiffus | 1994 |
Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis.
Topics: Acquired Immunodeficiency Syndrome; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole | 1994 |
Risk factors for hepatosplenic abscesses in patients with acute leukemia receiving empiric azole treatment.
Topics: Abscess; Acute Disease; Adolescent; Adult; Aged; Candidiasis; Female; Fever; Fluconazole; Humans; Le | 1994 |
Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome.
Topics: AIDS-Related Opportunistic Infections; Fluconazole; Histoplasmosis; Humans; Recurrence; Retrospectiv | 1994 |
Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype.
Topics: AIDS-Related Opportunistic Infections; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbi | 1994 |
The natural history of esophageal candidiasis after successful treatment in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Candidiasis; Esophageal Diseases; Fluc | 1994 |
Persistence of initial infection in recurrent Cryptococcus neoformans meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Blotting, Southern; Cerebrospinal Fluid; Diagnosis, | 1993 |
Pyrolysis typing of isolates from a recurrence of systemic cryptococcosis.
Topics: Aged; Aneurysm; Asthma; Blood Vessel Prosthesis; Cryptococcosis; Cryptococcus neoformans; Diabetes M | 1994 |
Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.
Topics: Adult; AIDS-Related Opportunistic Infections; Candida albicans; Candidiasis, Oral; DNA, Fungal; Drug | 1994 |
Medical treatment of recurrent candidemia in a patient with probable Candida parapsilosis prosthetic valve endocarditis.
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Endocarditis; Fluconazole; Fungemia; Heart V | 1994 |
Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases.
Topics: Administration, Oral; Adolescent; Adult; Amphotericin B; Aspergillosis; Aspergillus; Bone Marrow Tra | 1994 |
Native valve endocarditis due to Candida parapsilosis: a late complication after bone marrow transplantation-related fungemia.
Topics: Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Endocarditis; Female; Fluc | 1994 |
[Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS].
Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Drug Resistance, Micro | 1993 |
Treatment of Candida albicans fungaemia with fluconazole.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Candidiasis; Drug Administration Schedule; Female; Fluco | 1993 |
Weekly fluconazole for the suppression of recurrent thrush in HIV-seropositive patients: impact on the incidence of disseminated cryptococcal infection.
Topics: Adult; Antifungal Agents; Candidiasis, Oral; Cryptococcosis; Female; Fluconazole; HIV Infections; Hu | 1995 |
Treatment of native valve Candida endocarditis with fluconazole.
Topics: Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Follow-Up Studies; Heart Valve Di | 1995 |
Typing Candida albicans oral isolates from human immunodeficiency virus-infected patients by multilocus enzyme electrophoresis and DNA fingerprinting.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Carri | 1996 |
[Fluconazole in treatment of urinary candidiasis. Experience with 24 patients].
Topics: Adult; Aged; Aged, 80 and over; Candidiasis; Female; Fluconazole; Humans; Male; Middle Aged; Pyuria; | 1995 |
Persistence, replacement, and microevolution of Cryptococcus neoformans strains in recurrent meningitis in AIDS patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Base Sequence; Cryptococcus neoformans; DN | 1996 |
Vitrectomy and systemic fluconazole for treatment of endogenous fungal endophthalmitis.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Candidiasis; Combined Modality Therapy; Endoph | 1996 |
Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candida; Candidiasis, Oral; CD4 Lymphocyte Co | 1997 |
[Use of Diflucan in the treatment of chronic and recurrent candidosis with involvement of the esophagus].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Child; Chronic Disease; | 1996 |
Analysis of multiple failure time data from an AIDS clinical trial.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Clinical Trials, Phase III as | 1997 |
Single-dose systemic oral fluconazole for the treatment of vaginal candidiasis.
Topics: Administration, Oral; Adult; Antifungal Agents; Attitude of Health Personnel; Candidiasis, Vulvovagi | 1997 |
A case of recurrent Candida parapsilosis prosthetic valve endocarditis: cure by medical treatment alone.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Prost | 1997 |
Prediction of relapse after treatment of coccidioidomycosis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Coccidioidomycosis; Cohort Studies; Female; Fl | 1997 |
[Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis, Or | 1997 |
Infectious crystalline keratopathy caused by Candida guilliermondii.
Topics: Aged; Amphotericin B; Biopsy; Candida; Candidiasis; Cornea; Corneal Diseases; Drug Resistance, Micro | 1998 |
Recurrent cryptococcal choroiditis in a renal transplant patient: clinicopathologic study.
Topics: Adult; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Choroiditis; Cryptococcosis; Cryptoco | 1998 |
Analysis of multiple failure time data from an AIDS clinical trial.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents, Local; Antifungal Agents; Candidiasis; | 1998 |
Successful treatment of candidal osteomyelitis with fluconazole following failure with liposomal amphotericin B.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Female; Fluconazole; Humans | 1999 |
[Disseminated cryptococcosis in patients with AIDS. Prognostic factors of poor outcome].
Topics: Acute Disease; Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Analy | 1999 |
Cryptococcal meningitis in non-HIV-infected patients.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; C | 2000 |
Timed-kill curves for Cryptococcus neoformans isolated from patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococc | 2000 |
Candida albicans infection of a prosthetic knee replacement: a case report.
Topics: Antifungal Agents; Candidiasis; Cefuroxime; Cephalosporins; Device Removal; Fluconazole; Humans; Inj | 2000 |
An investigation into the pathogenesis of vulvo-vaginal candidosis.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Clotrimazole; Drug Resistance | 2001 |
Reactivated laryngeal coccidioidomycosis.
Topics: Adolescent; Biopsy, Needle; Coccidioidomycosis; Fluconazole; Follow-Up Studies; Humans; Injections, | 2001 |
Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Analysis of Variance; Antifungal Agent | 2001 |
Thrush in the breastfeeding dyad: results of a survey on diagnosis and treatment.
Topics: Adult; Antifungal Agents; Breast Diseases; Breast Feeding; Candidiasis; Candidiasis, Oral; Female; F | 2001 |
Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antifungal Agents; Diseas | 2001 |
[Candidemia in elderly people: apropos of 4 cases].
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Female; Fluconazole; Frail Elderly | 2002 |
Cutaneous cryptococcosis: recurrence following oral fluconazole treatment.
Topics: Administration, Oral; Aged; Cryptococcosis; Dermatomycoses; Female; Fluconazole; Humans; Recurrence | 1992 |
Recalcitrant onychomycosis of the toenails successfully treated with fluconazole.
Topics: Administration, Oral; Adult; Female; Fluconazole; Humans; Male; Onychomycosis; Recurrence | 1992 |
Dose-dependent fluconazole hepatotoxicity proven on biopsy and rechallenge.
Topics: Candidiasis, Oral; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug In | 1992 |
Rapid relapse of cryptococcal meningitis after termination of maintenance fluconazole in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cryptococcus neoformans; Fluconazole; Follow-Up Studies; | 1992 |
Suppressive therapy for cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Fluconazole; Humans; Meningitis, Cryptococcal; R | 1992 |
Suppressive therapy for cryptococcal meningitis.
Topics: Amphotericin B; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococca | 1992 |
[Cryptococcal meningitis in AIDS: successful long-term prophylaxis with fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antigens, Bacterial; Cryptococcus; Drug T | 1991 |
Fluconazole treatment of persistent Cryptococcus neoformans prostatic infection in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Confidence Intervals; Cryptococcosis; Fluconazol | 1991 |
Rhinofacial zygomycosis caused by Conidiobolus coronatus. A case report.
Topics: Aged; Agricultural Workers' Diseases; Brazil; Edema; Face; Female; Fluconazole; Fungi; Humans; Ketoc | 1991 |
[Candida esophagitis treated with a single dose of fluconazole in patients with HIV: presentation of 11 cases].
Topics: Adult; Candidiasis; Esophagitis; Female; Fluconazole; HIV Infections; Humans; Male; Prospective Stud | 1990 |
Prostatic cryptococcal infection.
Topics: Cryptococcosis; Fluconazole; Humans; Male; Middle Aged; Prostatic Diseases; Recurrence | 1990 |
Fluconazole in the treatment of persistent coccidioidomycosis.
Topics: Adult; Aged; Aged, 80 and over; Coccidioides; Coccidioidomycosis; Dermatomycoses; Female; Fluconazol | 1990 |
Severe systemic cryptococcal disease in a child: review of prognostic indicators predicting treatment failure and an approach to maintenance therapy with oral fluconazole.
Topics: Administration, Oral; Amphotericin B; Child; Cryptococcosis; Female; Fluconazole; Humans; Opportunis | 1990 |
Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus | 1989 |